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ABSTRACT

MAMMALIAN EGG ACTIVATION: THE ROLES OF TRPV3
CHANNELS AND PLCZ1
FEBRUARY 2016
HOI CHANG LEE, B.S., CHUNGBUK NATIONAL UNIVERSITY
M.S., KONKUK UNIVESITY
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Rafael A. Fissore

Calcium channels at the plasma membrane have been suggested to mediate Ca2+ influx
during egg activation. The transient receptor potential (TRP) Ca2+ channel, TRPV3, is
differentially expressed in oocytes during maturation, being fully active at MII stage.
Specific stimulation of TRPV3 channels in mouse eggs promotes Ca2+ influx sufficient to
induce egg activation and parthenogenesis. In chapter 2, we explore the function and
distribution dynamics of the TRPV3 channel protein during oocyte maturation. Using
dsRNA, TrpV3 overexpression, and inhibitors of protein synthesis, we modified the
native expression of the channel and showed that the TRPV3 protein is synthesized and
translocated to the plasma membrane during maturation. We demonstrated that 2-APB at
the concentration used to promote Ca2+ influx in eggs, specifically and reversibly targets
TRPV3 channels, and does not block the IP3 receptor. Finally, we showed that TRPV3
channels functionally interact with the actin cytoskeleton indicating an actin-based
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regulation of its expression on the plasma membrane. Our results indicated that TRPV3 is
a target of 2-APB in eggs, a condition that can be used to induce parthenogenesis. The
association of endogenous TRPV3 channels with the actin cytoskeleton is a novel
finding, and suggests that the rearrangements of actin that occur during maturation could
regulate both plasma membrane presence and function of TRPV3 Ca2+ channels involved
in oocyte maturation and fertilization. We show that TRPV3 is required for strontium
influx because TRPV3-KO eggs failed to conduct Sr2+ or undergo strontium-induced
activation. We propose that TRPV3 is a major mediator of calcium influx in mouse eggs
and is a putative target for artificial egg activation.
In chapter 3, we conducted studies to determine if expression of the testis-specific
PLCZ1 correlated with low success or fertilization failure after ICSI in patients with
normal parameters after standard semen analysis (SA). The presence of PLCZ1 in sperm
was ascertained using western blotting and immunofluorescence (IF) analysis. The ability
of sperm to initiate changes in the intracellular concentrations of [Ca2+]i was also
examined. Male partners of couples with failed or low success ICSI fertilization but with
normal SA parameters showed low expression levels of PLCZ1 as determined by western
blotting and reduced fluorescent signal during IF studies. In addition, fewer of these
males’ sperm showed PLCZ1 expression and were able to initiate robust [Ca2+]i
oscillations upon injection into eggs. In the second part of this chapter, we examined two
infertile brothers exhibiting normal sperm morphology but complete fertilization failure
after intra cytoplasmic sperm injection (ICSI). Whole exomic sequencing evidenced a
missense homozygous mutation in PLCZ1, converting Ile 489 into Phe (Ile489Phe). We
showed that the mutation is deleterious, leading to absence of the protein in sperm.
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Injection of cRNA into GV and MII oocytes showed that the protein was mislocalized
and produced highly abnormal Ca2+ transients and early embryonic arrest. Altogether
these alterations are consistent with our patients’ sperm inability to induce oocyte
activation and initiate embryo development. In contrast, no mutations were identified in
WBP2NL and PAWP presented normal expression and localization. Overall we
demonstrate in humans that the absence of PLCZ1 alone is sufficient to prevent oocyte
activation irrespective of the presence of PAWP. Additionally, it is the first mutation
located in the C2 domain of PLCZ1, a domain involved in targeting proteins to cell
membranes, opening the door for structure function studies to define the conserved amino
acids on the β1 strand of the C2 domain that might regulate the selectivity of PLCZ1 for
its lipid substrate(s).
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CHAPTER 1
BACKGROUND
1.1 Egg Activation
Increases in the intracellular concentration of free Ca2+ ([Ca2+]i) triggers the initiation,
progression and/or completion of a range of cellular processes, including fertilization,
muscle contraction, secretion, cell division, and apoptosis (1). In order to survive and
proliferate, cells must communicate with each other and within organisms, and changes
in [Ca2+]i allow them to quickly respond to environmental or metabolic challenges and
cues with reactions that regulate cell fate and function. In the case of Ca2+, myriad
proteins have acquired the ability to bind Ca2+, which allows them to interpret and
transform these elevations into cellular decisions and functions.
In most species, oocytes through the process of maturation, prepare for fertilization and
initiation of embryogenesis. In mammals, fully-grown oocytes remain arrested until
fertilization at the metaphase of the second meiotic division (MII) (2, 3). During
fertilization, sperm triggers a series of increases in the levels of [Ca2+]i, which are termed
Ca2+ oscillations that are responsible for oocyte activation (4). Oocyte or egg activation
is the process that transforms a ready-to-be-fertilized MII oocyte, also known as an egg,
into a competent zygote capable of supporting embryo development to term. Egg
activation, is characterized for many events including the resumption and progression of
meiosis, cortical granule (CG) exocytosis, prevention of polyspermy, release of the polar
body, sperm head decondensation and PN formation and translation, accumulation, and
degradation of specific mRNAs and proteins (5) (Figure 1-1). Increases in [Ca2+]i are the
universal signal of egg activation in all species investigated to date (6). Importantly, to
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support the long-persistence of oscillations, which are the hallmark of mammalian
fertilization, Ca2+ influx is necessary to refill the internal stores and maintain the
oscillations in all mammals (7-9).
The [Ca2+]i responses that underlie egg activation offer a great deal of diversity
regarding their spatiotemporal configuration, reflecting both the plasticity of the Ca2+
signaling machinery as well as the dissimilar Ca2+ requirements for egg activation among
species. In general, species can be categorized either as displaying a single [Ca2+]i rise, in
the case of sea urchins, starfish, frogs, and fish, or showing multiple [Ca2+]i increases,
also known as oscillations, in the case of nemertean worms, ascidians, and mammals (10,
11). Research has found that Src-family kinases (SFKs) and phospholipase Cγ (PLCγ) are
involved in the activation of the phosphoinositide pathway and production of inositol
1,4,5, -triphosphate (IP3) during fertilization in sea urchins, starfish, and frogs, reflecting
the contribution of a presently unknown plasma membrane receptor/signaling complex
(12, 13). Inositol 1,4,5-triphosphate (IP3)-mediated Ca2+ release from intracellular stores
in the endoplasmic reticulum (ER) is primarily responsible for the generation of the
[Ca2+]i wave and oscillations during fertilization in mammals. During these oscillations,
the production of IP3 production is upregulated, which mediates Ca2+ release via its
cognate receptor (IP3R), located in the ER, and in this form makes possible the
occurrence of [Ca2+]i oscillations(14).
Research now suggests that in mammals the initiation of oscillations may be
accomplished by a novel mechanism whereby the signaling molecule/cargo, known as the
sperm factor (SF), is released by the sperm into the ooplasm after fusion of the gametes.
Importantly, the SF is not IP3 or Ca2+ and rather contains a protein moiety (15-18). The
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mammalian SF’s molecular identity appeared to have been resolved when a new member
of the PLC family, a sperm-specific isoform named PLCZ (19), was reported to
reproduce the responses of the sperm. Nevertheless, the recent proposal of PAWP as an
alternative SF has raised some doubts about the true identity of the mammalian SF.
External Ca2+ is required to fill the internal stores from where Ca2+ is increased
internally. External can be incorporated into cells through channels and/or transporters.
One of the first characterized channels in mouse eggs (20) was the T-Type Voltage-gated
Ca2+ channel (21). The role of these channels in fertilization remains elusive (22), as
changes in membrane potential during mouse fertilization are negligible (23) and the
resting potential of mouse eggs is close to the activation threshold of these channels,
which suggests that a large majority of them might be inactive in MII eggs before and
after fertilization. Therefore, the identity of the channels that mediate influx to support
the oscillations in mammals remains unknown.

1.2 TRP channels
The transient receptor potential (TRP) proteins are the second largest class of nonselective cation channels. The founding member of the TRP family was identified nearly
40 years ago in Drosophila (24-26), which was defective in light sensing and exhibited
only transient light-induced receptor potentials (TRP) instead of the normal persistent
response (27). TRP channels are widely expressed in somatic cells. The TRP channel
superfamily contains 28 mammalian members subdivided in six subfamilies: TRP
canonical (TRPC; TRPC1-7), TRP vanilloid (TRPV; TRPV1-6), TRP melastatin (TRPM;
TRPM1-8), TRP ankyrin (TRPA; TRPA1), TRP polycystin (TRPP; TRPP2, 3, 5), and
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TRP mucolipin (TRPML; TRPML1-3) (28). All TRP channels are primary sixtransmembrane segments polypeptide subunits. The permeable cation pore is located
between the fifth and sixth transmembrane domains (Figure 1-2) (29). TRP channels can
sense a variety of stimuli such as light (26, 30, 31)[Montell C Neuron 1989, Hardie RC
Neuron 1992, Xue T Nature 2011], odors (32, 33), taste (34, 35), acids (36, 37),
temperature (38, 39), gravity (40), auditory stimuli (41, 42), as well as mild and noxious
mechanical forces (43-46). The stimuli that activate TRPs do so through a multistep of
downstream cellular signal pathways, or through a single step via Ca2+ entry and/or
membrane depolarization (46). TRP channels are also involved in cellular homeostasis
and growth control, regulation of cell fate and survival, immune and inflammatory
mechanisms, and endocrine and exocrine secretory processes (28).

1.2.1 TRPV family
Based on homology, the TRPV (vanilloid) family comprises six ion channels. There
are four main groups: TRPV1/TRPV2, TRPV3, TRPV4, and TRPV5/6. This family is
named after the first mammalian member of the TRPV subfamily, which binds vanilloids
(27). Among the TRPV channels, TRPV1, 2, 3 and 4 have striking temperature
sensitivities. Indeed, TRPV1 is activated at > 43°C; TRPV2 at >52°C; TRPV3 at 33°C;
and TRPV4 at >30°C (27). These thermo-TRPVs are modestly permeable to Ca2+,
whereas TRPV5 and TRPV6 are the only highly Ca2+ selective channels in the TRP
family. Nevertheless, functions of all of these channels are tightly regulated by [Ca2+]i
and phosphoinositides (27, 47).
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1.2.2 TRPV3
The voltage-independent member of the TRP channel family, TRPV3, was recently
reported to be functionally active in mouse eggs (48). TRPV3 shares 43% sequence
similarity with TRPV1. The initial characterization of TRPV3 expression was carried out
in somatic tissues and the brain, spinal cord, testis, skin, oral cavity, and gastrointestinal
tract showed high levels of expression (49, 50); reviewed in (51). TRPV3 was found to
be activated by innocuous warm temperatures above 33°C (27, 49, 50, 52). The role of
TRPV3 as a thermosensor is still not completely understood. TRPV3 knockout mice
exhibit strong deficits in responses to innocuous and noxious heat but not in other sensory
modalities (27, 53).
In mice, TRPV3 is involved in the formation and maintenance of the physicalchemical skin barrier. TRPV3 forms a signaling complex with the receptor of epidermal
growth factor (EGFR) and transforming growth factor-α (TGF-α). Activation of EGFR
leads to increased TRPV3 channel activity, which in turn stimulates TGF-α release
resulting in the formation of the barrier (54). Lack of the trpv3 gene in mice results in
particular hair phenotypes (wavy hair coat and curly whiskers) (54). Functional TRPV3
channels were identified in cultures of hair follicle-derived outer root sheath
keratinocytes, in which the activation of TRPV3 and the concomitant elevation of [Ca2+]i
resulted in inhibition of cell growth and the onset of cell death (55).
Native TRPV3 currents were first reported in keratinocytes, where exposure to 100 µM
2-Aminoethoxydiphenyl borate (2-APB), a known activator of the TRPV3 channel, only
caused whole cell currents when cells were sensitized with temperature (56).
Remarkably, TRPV3 channels are expressed in MI oocytes and MII eggs are capable of
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generating strong and measurable whole cell currents after 2-APB treatment without
temperature exposure, suggesting different regulation or sensitization of native TRPV3
channels in eggs (48). !

1.3 Sperm factor
In mammals, repetitive [Ca2+]i transients are induced soon after sperm-oocyte fusion
(7, 57), which trigger the events of egg activation (58). Furthermore, the amplitude and
number of [Ca2+]i rises might affect gene expression at later stages of embryo
development and even after postnatal development (59). The mechanism by which the
sperm induces [Ca2+]i oscillations involves IP3 (58, 60). IP3 is generated by phospholipase
C (PLC), which causes hydrolysis of phosphatidyl inositol 4,5-bisphosphate (PI(4,5)P2).
How the PLC is activated during fertilization has been investigated for several decades,
and three major hypotheses have been proposed (61-63). The first is the ‘membrane
receptor hypothesis’, which suggested that an egg surface receptor was engaged by a
sperm resulting in the production of a signaling pathway that activated PLC and triggered
Ca2+ release (64). Another idea is the ‘conduit hypothesis’, which proposed that
extracellular Ca2+ flowed into the egg during sperm and gamete fusion, although this
notion was quickly abandoned once it was shown that [Ca2+]i increases occurred in the
absence of external Ca2+. The third hypothesis is the ‘sperm factor hypothesis’, which
since the advent of intracytoplasmic! sperm! injection (ICSI), which demonstrated that
activation could happen in the absence of interaction of the gametes, is considered the
mechanism whereby fertilization initiates [Ca2+]i oscillations. In support of this
hypothesis, injection of sperm cytosolic extracts into eggs results in [Ca2+]i responses
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similar to those observed during fertilization in many species, including sea urchin (65),
ascidian (66), chicken (67), hamster (68), mouse (69), rat (70), cow (16), pig (71), human
(72), and rabbit (73).

1.3.1 PLCZ
Saunders et al. showed evidence that phospholipase C zeta (PLCZ) might be the
sperm-borne oocyte-activating factor. For example, microinjection of cRNAs encoding
for mouse PLCz1 (19) or recombinant PLCz1 protein (74) induced [Ca2+]i oscillations
highly reminiscent of those during fertilization. Furthermore, depletion of PLCZ form
sperm extracts removed the ability of these extracts to initiate oscillations. (19). It was
also demonstrated that the content of PLCz1 in a single sperm was compatible with the
concentrations required to induce oscillations (19). Others reported that reducing sperm
PLCz1 levels by a transgenic RNA interference resulted in perturbation in patterns of
[Ca2+]i oscillations after fertilization and reduced litter size (75). PLCZ1 has been
detected in all mammalian species investigated to date, including mouse (19, 70), rat
(70), human (70, 76), and also in some non-mammalian species (65-67).

1.3.2 Structure and Function of PLCZ
There are 13 known mammalian PLC isozymes classified according to their structure
into six groups: PLC-beta (PLCβ 1-4), -gamma (PLCγ 1, 2), -delta (PLCδ 1, 3, 4), epsilon (PLCε), -zeta (PLCζ), and –eta (PLCδ 1, 2) (77-79), of which PLCζ is the
smallest (80). PLCZ is composed of four EF-hand (EF1-EF4) domains in the N terminus,
catalytic X and Y domains, and a C2 domain in the C terminus, which are domains
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common to all other PLCs. However, PLCZ lacks the N-terminal PH domain that is
found in PLCβ, -γ, -δ, and –ε, which underlies their interaction with membrane
phospholipids and the localization of those PLCs to the PM (81).
PLCZ has a very distinct functional property, which is the high Ca2+ sensitivity of its
in the PIP2 hydrolyzing activity. PLCZ and PLCδ1, which exhibits comparatively high
homology with PLCZ, have a similar affinity for PI(4,5)P2, but PLCZ is more sensitive to
Ca2+ than PLCδ1, which in other words means it can hydrolyze PIP2 at lower, basal,
concentrations of Ca2+ (82). These properties are thought to depend on the N-terminal
EF-hand domains, as the absence of the all EF hands results in complete loss of the PIP2
hydrolyzing activity and [Ca2+]i oscillations inducing activity of PLCZ1 (83). EF1 and
EF2 are also important for PLCZ activity because deletion of these domains remarkably
reduces PLCZ activity (83). However, point mutations in EF1 or EF2 do not cause a
marked decline in the Ca2+ sensitivity of the PIP2-hydrolyzing activity (83), suggesting
the two EF-hand domains play a structural role to form the active conformation rather
than being a Ca2+-binding site for the catalytic activity (83) (Figure 1-3).
The C2 domain, which consists of approximately 37 amino acids in the C terminal
end of PLCZ, is required for PLC activity and Ca2+ oscillatory activity, as its deletion
causes complete loss of PLC activity (83). The C2 domain has been characterized as a
membrane-associating and intermolecular interaction domain in a variety of proteins
(84). It has been suggested that the C2 domain plays part in the Ca2+-dependent
subcellular membrane targeting for several lipid-metabolizing enzymes (85, 86).
Therefore, there is a possibility that the C2 domain of PLCZ also functions as its PIP2
binding site. On the other hand, it has been also reported that the C2 domain does not
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play a direct role in the interaction with PIP2 because in in vitro studies PLCZ∆C2
showed binding to PI(4,5)P2 with equivalent affinity to wild-type PLCZ (87). Instead, it
has suggested that the X-Y linker region PLCZ, which shows strong binding to PI(4,5)P2
might be the substrate targeting enzyme for PLCZ1 (87) (Figure 1-3).
The X and Y domains are associated with the catalytic activity common to all
phosphoinositide-specific PLCs. It has been reported that the X and Y catalytic domains
are capable of binding and hydrolyzing PIP2 because even with the XY catalytic domains
alone, that is without the other domains of the enzyme, in vitro studies show it exhibits
well over half of the activity of full-length PLCZs (82) (Figure 1-3).
The linker region connects the X and Y domains. This domain in PLCZ is longer than
in other PLCs, and it appears to host a nuclear localization signal sequence, which is
thought to be a binding site for the nuclear transport receptor, and explains the ability of
mouse PLCZ to undergo nuclear translocation (88, 89). Consistent with this, following
fertilization and PN formation, PLCZ accumulates into the PN (90, 91), and this
localization contributes to the termination of the oscillations around the time of the time
of PN formation in mouse zygotes (2). Therefore, it has been suggested that the
translocation of PLCZ plays a important role in the cessation of [Ca2+]i oscillations
observed at the interphase of a cell cycle in mouse zygotes (91, 92). Curiously, mPLCz1
is thus far the only member able to translocate to the PN, as human, rat, medaka fish (70),
horse (93) and bovine PLCZs (94) are unable to accumulate in the PN despite the
containing the highly conserved nuclear localization signal. Therefore, the physiological
function of PLCZ translocation to the PN and the termination of the oscillations at the PN
stage remain unclear.
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1.3.3 Localization of PLCZ in sperm
The localization of PLCZ in the sperm of several mammalian species has been reported
and it appears variable. A word of caution is needed here, as in most cases the antibodies
used show cross reactivity with unknown proteins, therefore raising questions regarding
the accuracy of the reported information. For example, in mouse sperm, PLCz1
localization was reported in both post-acrosomal region (95) and acrosomal regions (96),
which was also the case for hamster sperm (96), whereas in rat sperm the localization
seemed mostly to concentrate, in the acrosomal region (97). In human sperm, PLCZ1 was
found in the equatorial (98) and equatorial and post-acrosomal regions (99). In large
domestic species, whereas in the bull appeared almost exclusively in the equatorial region
(95), in equine sperm appeared in the acrosome, equatorial region, head-midpiece
junction and tail of equine sperm (100), which was similar to the distribution in pig sperm
(101). In addition to the specificity of the antibodies, the localization of PLCZ1 may be
affected by the status of sperm, i.e., whether or not capacitated or acrosome reacted. For
instance, in humans, the proportion of sperm displaying the equatorial/acrosomal location
distribution decreased, whereas the equatorial/post-acrosomal pattern increased after
capacitation and ionophore treatment (102). Presently, it is not not known whether PLCZ
protein undergoes redistribution during these events or the accessibility of the antibodies
changes during capacitation and acrosome reaction.

1.3.4 PAWP
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In 2007, Dr. Oko and colleagues reported that a novel alkaline extractable protein of
the sperm head that exclusively resides in the post-acrosomal sheath region of the
perinuclear theca (PT) might also be capable of inducing oscillations in mammalian eggs
(103). Molecular cloning of PAWP has been reported in humans, mice and cows (103). It
consists of 309 (human), 354 (mouse) and 313 amino acids (cow), and the N-terminal
half of PAWP shares a 49% sequence similarity to WW domain binding protein 2. As for
the C-terminal half of PAWP, Wu et al. (2007) showed that it contains an unidentified
repeating motif (YGXPPXG (where X represents any residue). The protein was named
PAWP (Postacrosomal sheath WW domain-binding protein). PAWP was detected in the
cytoplasmic droplets of spermatids beginning to undergo elongation in mice, rabbits,
pigs, cows, rhesus monkeys and humans using a PAWP antibody (103-105). Upon
injection of recombinant human PAWP or alkaline PT extracts into porcine, bovine,
macaque, and Xenopus oocytes, the authors revealed high incidence of PN formation and
suggested PAWP mihgt be a candidate to be a sperm factor. On the other hand, coinjection of PAWP with a competitive peptide containing the PPXY motif prevented the
effects of PAWP on activaiton on several species. To extend those results, the
investigators examined whether injection of PAWP could induce oscillations. To that
end, Aarabi et al. demonstrated that injection of recombinant human PAWP caused a
[Ca2+]i release in Xenopus oocytes (106), and also oscillations in mouse eggs (107).
Nevertheless, given the lack of sequence homology to known signaling molecules, it
remains unknown how this protein could trigger oscillations. Towards that end, attempts
to replicate the results with PAWP in mouse oocytes have failed (108, 109), and a recent
reported PAWP null mice line showed normal spermatogenesis and fertility (110).
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Therefore, the role of PAWP at best remains thus uncertain in the mouse, although the
possibility that a human oocyte specific factor is needed was not ruled out. Indeed,
numerous studies have shown that testis and reproductive tissues evolve faster than other
tissues leading to noticeable differences between species (111).
!
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CHAPTER 2
THE ROLES OF TRPV3 CHANNELS IN MOUSE EGGS
Summary
Mammalian fertilization is initiated when a sperm fuses with a mature metaphase II
(MII) oocyte, also known as an egg, and triggers a plethora of finely controlled processes
identified as egg activation. The completion of early and late events of egg activation is
driven by and depends on a series of repetitive [Ca2+]i oscillations, which rely on Ca2+
influx. Ca2+ channels at the plasma membrane have been suggested to mediate Ca2+
influx during egg activation. The TRP Ca2+ channel TRPV3 is differentially expressed in
oocytes during maturation, being fully active at the MII stage. Specific stimulation of
TRPV3 channels in mouse eggs promotes Ca2+ influx sufficient to induce egg activation
and parthenogenesis. Here, we explore the function and distribution dynamics of the
TRPV3 channel protein during oocyte maturation. Using dsRNA, TrpV3 overexpression,
and inhibitors of protein synthesis, we modified the native expression of the channel and
showed the TRPV3 protein is synthetized and translocated to the plasma membrane
during maturation. We demonstrated that 2-APB at the concentrations used to promote
Ca2+ influx in eggs, specifically and reversibly targets TRPV3 channels, and it does not
block the IP3 receptor. Finally, we showed that TRPV3 channels functionally interact
with the actin cytoskeleton indicating an actin-based regulation of its expression on the
plasma membrane. Our results show that TRPV3 is a target of 2-APB in eggs, a condition
that can be used to induce parthenogenesis. The association of endogenous TRPV3
channels with the actin cytoskeleton is a novel finding, and suggests that the
rearrangements of actin that occur during maturation could regulate both plasma
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membrane presence and function of TRPV3 Ca2+ channels involved in oocyte maturation
and fertilization. We show that TRPV3 is required for strontium influx because TRPV3KO eggs failed to conduct Sr2+ or undergo strontium-induced activation. We propose that
TRPV3 is a major mediator of Ca2+ and/or other divalent cations influx in mouse eggs
and is a putative target for artificial activation of mouse eggs.

2.1 Introduction
Under natural conditions, egg activation starts with fertilization and includes initiation
of calcium ([Ca2+]i) oscillations, which trigger egg activation (reviewed in (5)). [Ca2+]i
increases are the universal signal of egg activation in all species investigated to date (6),
whereas Ca2+ influx is necessary to support the long-lasting oscillations in mammals,
which are the hallmark of mammalian fertilization (7, 8). External Ca2+ can be
incorporated into cells through channels and/or transporters. One of the first characterized
channels in mouse eggs were the T-type Voltage-gated Ca2+ channels (CaV 3.2; (21));
although, the function remains elusive as CaV 3.2-deficient female mice are fertile (22).
Changes in membrane potential during fertilization are negligible (23), and the resting
membrane potential of mouse eggs is close to the activation threshold of the CaV
channels, which suggests that a large proportion of them might be inactivate in eggs
before and after fertilization. The voltage-independent member of the TRP channel
family, TRPV3, was also reported to be functionally active in mouse eggs (48). Native
TRPV3 currents were first reported in keratinocytes, where addition of 100 µM 2-APB, a
known activator of TRPV3 channels, elicited measurable changes in whole cell currents
only in cells previously sensitized by temperature (56). Remarkably, TRPV3 channels
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expressed in MI oocytes and eggs respond to 2-APB treatment with quantifiable whole
cell currents without previous temperature exposure, suggesting different regulation or
sensitization of native TRPV3 channels in mouse eggs (48). In this study, we artificially
overexpressed the wild type channel tagged with fluorescent fusion protein to evaluate its
localization in mouse oocytes and eggs. We showed that the exogenous and endogenous
channel protein is synthetized during maturation and is translocated to the plasma
membrane (PM) where it is fully responsive to 2-APB at the MII stage.
Since its initial use as specific inhibitor of the IP3R1 (112), an ubiquitously expressed
channel that mediates intracellular Ca2+ release in most cell types (1), 2-APB has been
shown to block (or to activate, depending on the concentration and isoform) Ca2+-ATPase
pumps, SERCA (113), and other channels (114), including TRP channels where it was
described as an “unspecific” blocker (115) 2-APB was also shown to activate TRPV1,
TRPV2 and TRPV3 (116), and in fact, it is the most used activator of TRPV3 channels
(56, 116). 2-APB is also an agonist of ORAI3 (117), one of the proteins that are
molecular correlates, together with STIM, of the Store-Operated Ca2+ channels or CRAC
channels (114). 2-APB was therefore also used to test the presence of ORAI3 in mouse
oocytes and eggs, and the Ca2+ influx promoted by 2-APB in these cells was taken as
confirmation of ORAI3 expression (118). Nevertheless, a previous report showed that 2APB was unable to promote Ca2+ influx in TrpV3-KO eggs (at 100 µM (48)), suggesting
TRPV3 is the only channel responsible for mediating the effects of 2-APB in mouse
eggs. Using molecular and functional assays we show that the agonist effect of 2-APB in
mouse oocytes and eggs is specifically mediated by TRPV3. We also demonstrated that
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concentrations of 2-APB known to inhibit Ca2+ influx (119) do not block the function of
IP3R1 in oocytes.
Actin is a major cytoskeletal protein found ubiquitously within eukaryotic cells. Actinbased cytoskeleton complexes are involved in the dynamic of channels at the PM
including endocytosis/exocytosis and intracellular trafficking (120), and can also
modulate the activity of channels while on the membrane surface (121). Cytoplasmic
actin filaments have been shown to function in mitosis and meiosis, especially in oocytes,
eggs and blastomeres (122). These functions are related with positioning and assembly of
the meiotic spindle as well as general organization and redistribution of organelles (122,
123). To that end, actin interacts with the ARP2/3 protein complex that becomes
activated in the cortical region, where it nucleates a thick cortical actin layer termed
“actin cap”, which is essential for cytoplasmic flow (124). The reorganization of the
cytoplasm during maturation correlates with changes in the functional expression of
TRPV3 channels (48), which suggests an association between actin reorganization,
redistribution, and incorporation of these channels into the PM. In this study, we
hypothesized that TRPV3 channels actively interact with the actin cytoskeleton in mouse
oocytes and eggs. Our results propose a close functional relationship between actin and
TRPV3 channel presence in the PM, suggesting that intact microfilament organization
may regulate the function of TRPV3 and other PM channels involved in Ca2+
homeostasis in oocytes and eggs.
Mammalian eggs can be parthenogenetically activated by a variety of artificial stimuli.
Replacement of external Ca2+ by 5-10 mM strontium (Sr2+) has been extensively used to
induce egg activation in rodents (7, 125). This procedure is not associated with
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chromosome abnormalities and is capable of promoting full-term development when
combined with somatic cell nuclear transplantation (126). Importantly, it is unknown
what channel(s) mediates the influx of Sr2+ in mouse oocytes, although the temperature
regulation of TRPV3 channels and the reported sensitivity of Sr2+ influx to temperature
makes them ideal candidates (48).

2.2 Results

2.2.1!Functional!expression!of!TRPV3!channels!progressively!increases!during!
oocyte!maturation!!
Since significant changes take place in Ca2+ signaling in oocytes and eggs (2, 14, 127),
we explored changes in TRPV3 functional expression in oocytes at different stages of
maturation. During the GV stage, addition of 100 µM 2-APB did not induce a measurable
current (Figure 2-1A) in these cells, and Ca2+ imaging studies confirmed those findings
(Figure 2-1A and D). Once oocytes had undergone germinal vesicle breakdown (GVBD)
and progressed to MI (Figure 2-1B), application of 2-APB evoked a TRPV3 current
(Figure 2-1B) of 23 ± 2pA/pF (Figure 2-1D, left panel) as well as a [Ca2+]i increase
(Figures 2-1B and D). At MII (Figure 2-1C), when eggs become competent to mount
oscillations in response to fertilization, TRPV3 channels responded to 2-APB with a
current of 73 ± 6 pA/pF (Figure 2-1C and D), which is significantly higher than in MI
eggs. Thus, TRPV3 more densely populates the MII membrane compared to the MI
membrane (in channels/ µm2). Despite their much smaller surface area (120 ± 7pF versus
226 ±9.5 pF, Figure 2-1D, middle panel) and higher TRPV3 channel density, [Ca2+]i
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increases in MII eggs were similar in magnitude to those in MI (Figure 2-1C), reflecting
the lower sensitivity of Ca2+ measurements compared with direct voltage clamp
recordings of currents to monitor transport of ions across the PM, which is due to native
Ca2+ buffers and variations in resting membrane potential in unclamped oocytes.
Addition of Ionomycin, a Ca2+ ionophore that under Ca2+ -free conditions causes Ca2+
release from the intracellular stores, induced a response in all stages of maturation
(Figure 2-1A-C, lower panel), confirming the healthy status of the our cells. Our results
therefore show that the number of TRPV3 channels increase during oocyte maturation,
being undetectable with electrophysiological recordings in the GV stage and reaching
maximal absolute numbers of functional channels in the MII stage (0.1 channels/µm2 in
MII, assuming an equal open probability, P0= 0.5 for both stages). They also show that
ion channel density in oocytes and eggs is very low compared to excitable cells in which
these values are typically 103- to 104 – fold larger (128).

2.2.2 Carvacrol, a TRPV3 agonist, induces [Ca2+]i responses and activation in mouse
eggs.
Carvacrol, the major ingredient in oregano, elicits TRPV3 mediated currents in
heterologously expressing cells and in primary keratinocytes (54). Because heterozygous
(V3-Het) eggs had robust TRPV3 currents in response to 2-APB, we performed
functional studies in eggs isolated from V3-Het and knockout (V3-KO) littermates.
Addition of 50 µM carvacrol to V3-Het eggs evoked a substantial increase in [Ca2+]i
(Figure 2-2A, left panel) and responded with an additional [Ca2+]i increase following
addition of 200 µM 2-APB. In contrast, eggs from V3-KO mice failed to respond to
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either agonist (Figure 2-2A, right panel). We next tested whether stimulation of TRPV3
channel causes egg activation. Incubation of wild type (WT) and V3-Het eggs with 50
µM carvacrol provoked parthenogenesis as PN formation was observed within 5 hr after
carvacrol treatment in roughly half of the mature eggs (Figure 2-2B and C). Cleavage to
the 2-cell stage was observed 24 hr after treatment (67% ± 3% in WT eggs and 56% ±
4% in V3-Het eggs, Figure 2-2B and D).

2.2.3 TRPV3-mediated Ca2+ influx is not required for maintenance of Ca2+
oscillations.
The fertilization-associated [Ca2+]i oscillations that underlie activation of mammalian
eggs are thought to be triggered by the sperm-specific PLCZ. PLCZ activates the egg’s
phosphoinositide pathway to generate IP3, which, in turn, gates the endoplasmic reticular
Ca2+-permeant IP3R (11, 19). Although the first few oscillations of Ca2+ rely on internal
Ca2+ stores, the persistence of the Ca2+ oscillations requires Ca2+ influx (7, 23). To
ascertain whether TRPV3 channels are required for these oscillations in response to
fertilization, we examined sperm-induced Ca2 oscillations in V3-KO and V3-Het MII
eggs. We observed the first [Ca2+]i transients 5-10 min after addition of sperm (Figure 23A; see (129)). No differences were found for in vitro fertilization success, assessed as
the rate of 2-cell formation between V3-KO and V3-Het eggs (Figure 2-3B). We next
examined whether the activity of TRPV3 channels was required to support oscillations
induced by injection of Plcz cRNA. These oscillations, which were monitored for 6 hr,
were similar in V3-KO and V3-Het MII eggs with respect to time of initiation, amplitude,
frequency, and duration (Figure 2-3C). These data suggest that PLCZ does not
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substantially potentiate TRPV3 as a mechanism of its action on Ca2+ oscillations.
However, addition of 200 µM 2-APB to V3-Het eggs that were undergoing oscillations at
37°C dramatically increased Ca2+ influx and prevented [Ca2+]i from returning to baseline,
immediately blocking oscillations in V3-KO eggs (Figure 2-3C). Finally and as expected,
the addition of the TRPV3 agonist, carvacrol (50 µM), to oscillating WT eggs increased
Ca2+ influx and immediately halted the oscillations by preventing the return of [Ca2+]i
back to baseline.

2.2.4 TRPV3 channels mediate Sr2+ influx and subsequent egg activation
Sr2+ has been widely used to induce parthenogenesis in rodent eggs (130, 131). The
channel that mediates Sr2+ influx has not been reported in any species, and whether Sr2+
and Ca2+ permeate the same channels in mouse eggs is unknown. To ascertain whether
the TRPV3 channel mediates Sr2+ influx, we recorded the heat-activated TRPV3 current
in V3-Het and V3-KO cells in the presence of an extracellular solution containing 10 mM
SrCl2 and normal [Ca2+] (~10 µM) (Figure 2-4A). The absence of inward Sr2+ current in
V3-KO eggs correlates with the lack of SrCl2-induced oscillations in these eggs (Figure
2-4B) and their inability to become activated in media supplemented with SrCl2, as
assessed by 2-cell formation (Figure 2-4C and D). Nearly all WT eggs (89%±11%) and
over half of V3-Het eggs (61% ± 5.3%) became activated in these experiments.

2.2.5 2-APB promotes repetitive [Ca2+]i rises by promoting Ca2+ influx
To confirm that [Ca2+]i increases induced by 2-APB are caused by Ca2+ influx and are
not due to off target effects of the drug (113), we exposed MII eggs to sequential 10 min
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pulses of 2-APB interspersed with intervals without it in Ca2+ containing media. This
treatment resulted in immediate [Ca2+]i increases with [Ca2+]i levels remaining elevated
throughout the presence of the agonist. Washout of 2-APB caused a rapid return of
[Ca2+]i values to basal levels (Figure 2-5 left panel). Exposure to 2-APB in the absence
of extracellular Ca2+ failed to cause any [Ca2+]i increase, although re-addition of Ca2+
was followed by a progressive rise in [Ca2+]i until reaching peak levels (Figure 2-5, right
panel). These results show that 2-APB- induced [Ca2+]i increases in MII eggs are due to
Ca2+ influx and are caused by selective opening of TRPV3 channels by 2-APB.

2.2.6 Inhibition of protein synthesis undermines the response to 2-APB in oocytes
and eggs
GV oocytes do not express TRPV3 channels on the PM, although the channel is
functionally present in eggs, suggesting that protein translation and/or translocation of the
channel to the PM takes place during the late stages of maturation. To more closely
investigate the dynamics of TRPV3 function during maturation, we performed in vitro
maturation and examined the response to 2-APB at different time points during the
process. Maturation was conducted in the presence and/or absence of cycloheximide
(CHX), a protein synthesis inhibitor, as we assumed that preventing protein translation
would reduce the availability of TRPV3 channels. CHX was added 4 hr after the
initiation of maturation, to allow initial synthesis of cyclin B, a member of the maturation
promoting factor (MPF) complex, to ensure better progression through meiosis [S Brunet,
2005]. At the same time, we supplemented the media with colcemid (COL), a
microtubule polymerization inhibitor that by preventing the formation of the spindle
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should favor cyclin synthesis and avoid transition into interphase (132). We anticipated
that this was necessary as in the presence of lower levels of cyclin B and MPF activity
following CHX treatment, MI oocytes may prematurely enter interphase instead of
remaining arrested at M-phase; COL does not interfere with initiation and persistence of
oscillations at the MII stage (2). Therefore, after maturation for 8, 10 or 12 hr, control
oocytes and oocytes treated only with COL responded to 2-APB for the first time at 8 hr
post-initiation of maturation with a small and transient [Ca2+]i increase (Figure 2-6, left,
upper panel; middle, upper panel). Two additional hours of maturation (10 hr post
initiation of the essay), greatly enhanced [Ca2+]i responses to 2-APB, with the rises being
large and sustained (Figure 2-6, left middle panel; middle, middle panel). The responses
to 2-APB treatment increased even further by 12 hr of maturation, which is the time at
which oocytes reach the MII stage, and the responses had amplitudes nearly twice as
large as those at 10 hr [Ca2+]i levels remained at peak values throughout the monitoring
period (Figure 2-6, left bottom panel; middle bottom panel). Oocytes matured in the
presence of CHX+COL also initially responded to 2-APB by 8 h post maturation,
comparable to controls. However, [Ca2+]i responses to 2-APB by 10 and 12 hr post
maturation were greatly reduced in CHX- treated cells both in persistence (10 hr) and
amplitude (12 hr) (Figure 2-6, middle and bottom right panels). These results suggest that
protein synthesis of TRPV3 channel occurs during middle and late stages of maturation,
rendering mouse eggs sensitive to Ca2+ influx stimulated by 2-APB.

2.2.7 Overexpression of TRPV3 promotes Ca2+ influx in GV oocytes
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Given the stimulatory effects of 2-APB towards TRPV3 channels (116), we tested the
function of RFP-TRPV3 channels. As expected, in non-injected GV oocytes, 200 µM 2APB failed to trigger an increase in [Ca2+]i, (Figure 2-7A, left panel (48)), whereas it
triggered a [Ca2+]i increase in GV oocytes injected with Rfp-mTrpV3 (Figure 2-7A, right
panel) suggesting TRPV3 is the only channel responsible for Ca2+ influx in mouse
oocytes.
To extend these results given that TRPV3 accumulates during maturation, we performed
the converse experiment and attempted to prevent expression of TRPV3 channels during
maturation (48) using double strand (ds) RNA technology. To this end, GV oocytes were
injected with dsRNAs targeting the endogenous TrpV3 mRNA or Venus (control) and the
impact on TrpV3 RNA levels was evaluated using RT-PCR. Injection of dsRNA-TrpV3
effectively decreased RNA levels (Figure 2-7 B, left panel, lane 7; Figure 2-7 B, right
panel), whereas Venus dsRNA had no effect on the levels of TrpV3 mRNA (Figure 2-7
B, left panel, lane 5; Figure 2-7 B, right panel). Following in vitro maturation, we
examined the ability of these eggs to respond to 2-APB stimulation. As previously
shown, control non-injected eggs (48) and DsRNA-Venus injected eggs showed the
expected [Ca2+]i increase after addition of 2-APB (Figure 2-7 C, left panel [I. Carvacho,
2013]; Figure 2-7 D, right panel), whereas eggs injected dsRNA-TrpV3 showed reduced
responses (Figure 2-7 C, right panel), confirming the role of this channel in mediating
responses to 2-APB.

2.2.8 TRPV3 channels localize to the PM of oocytes, eggs and zygotes
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Previous studies using whole-cell patch-clamp methods showed TRPV3 channels are
expressed on the PM of MI oocytes and MII mouse eggs (48). However, the subcellular
localization and trafficking of TRPV3 during maturation was not characterized, in part
due to the lack of specific antibodies. To overcome this limitation, we injected RFPTrpV3 mRNA into GV oocytes and incubated them for 8 hr in media containing IBMX to
allow protein translation. GV oocytes were then allowed to resume meiosis and reach the
MII stage while the localization of RFP-TrpV3 throughout maturation was monitored.
Endogenous TRPV3 channels are not expressed on the PM of GV oocytes, at least as
defined by functional evidence provided by electrophysiological and Ca2+ monitoring
studies (48) (Figure 2-7 A, left panel); although, exogenous TRPV3 channels were
observed on the PM of GVs injected with TrpV3 mRNA (Figure 2-8, Upper panel, GV).
Following completion of maturation at the MII stage, RFP-TRPV3 channels remained on
the PM (Figure 2-8, Middle panel, MII); although there appeared to be more cytoplasmic
staining, possibly associated with trafficking of the channel and/or excess of protein
synthesis caused by the overexpression (Figure 2-8, Middle panel, MII). Consistent with
an excess of functional TRPV3 channels in MII oocytes injected with TrpV3 mRNA, a
small percentage of these oocytes, ∼10-15%, failed to arrest and spontaneously
progressed to the PN stage (Figure 2-8, lower panel, PN), in contrast to control noninjected oocytes, which always arrested at the MII stage

2.2.9 Actin cytoskeleton regulates the function of TRPV3 channels in the egg
membrane

!

24!

Functional interaction between TRP channels and the actin cytoskeleton is well
established (133, 134); although it is unknown whether interactions between TRPV3
channels and the actin microfilament occur and if they might affect TRPV3 function
and/or distribution. To explore these possibilities, we exposed eggs to LatA, which is an
actin polymerization inhibitor that modifies the organization of the egg cortex (135). As
expected, in control conditions, 2-APB increased [Ca2+]i in all cells (Figure 2-9A, left
panel), whereas eggs exposed to LatA (5 µM, 30 min) showed lower responses to 2-APB
(Figure 2-9A right panel), which was also clearly delayed (Figure 2-9A, right panel;
Figure 2-9B). We next examined the effect of LatA on oscillatory responses, which are
induced in mouse eggs by incubation in 5-10 mM Sr2+ (131, 136, 137). TRPV3 channels
have been shown to mediate Sr2+ oscillations in mouse MII eggs (48), and the expectation
was that disruption of cortical actin might affect Sr2+-induced oscillations. Consistent
with a role of actin on TRPV3 function, Sr2+-induced oscillations were reversibly blocked
by LatA treatment (Figure 2-9C).
In agreement with the Ca2+ imaging results, analysis of TRPV3 distribution following
using confocal microscopy showed changes in its cellular localization following
treatment with LatA- (Figure 2-10 A-L). In control GVs and MII eggs injected with RFPTrpV3 mRNA, the exogenous protein showed a clear PM localization (Figure 2-10 A, E,
I), which was disrupted by addition of LatA (Figure 2-10 B, F, J). Addition of LatA
reduced the presence of TRPV3 on the PM and increased its presence in the ooplasm, and
these changes in distribution are reflected by the ratio of fluorescence intensity between
cytoplasm and PM and are proportional to the duration of the LatA treatment (Figure 210 C and D, G and H, K and L; *, P<0.05) (138). In short, the longer the duration of
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exposure to LatA, the greater the redistribution of TRPV3 from the PM to the ooplasm,
as evidenced in MII eggs exposed to LatA for 2 hr (Figure 2-10 L). All together these
results suggest a direct and/or indirect interaction between TRPV3 and the actin
cytoskeleton, which is capable of affecting the function and distribution of TRPV3, and
possibly other channels on the PM.

2.2.10 2-APB does not block the function of IP3R1 in mouse eggs
In a previous study we showed that [Ca2+]i oscillations induced by injection of mPLCζ
mRNA in TrpV3-KO eggs were nearly identical to those of wild type eggs with an
exception: addition of 2-APB did not block mPLCζ cRNA induced oscillations in wild
type eggs, whereas it blocked mPLCζ induced [Ca2+]i oscillations in TrpV3-KO eggs
(48). Interpretation of those results indicates that in TrpV3-KO eggs, 2-APB becomes an
inhibitor of the channel(s) that support influx at fertilization, with mPLCZ mRNA being
used as a proxy for fertilization. However, as previously mentioned, 2-APB is a broad
spectrum inhibitor of the TRP family of channels, of the SERCA pump (113) and even of
IP3R1 (112), and inhibition of oscillations by 2-APB in TrpV3-KO eggs is due to
inhibition of IP3R1 cannot be ruled out. To test the effect of 2-APB on the mentioned
receptor, we injected eggs with caged IP3 which is released by pulses of UV light and
causes [Ca2+]i responses (Wakai T, 2012). In control eggs, repeated UV pulses caused
single and sharp [Ca2+]i increases (Figure 2-11, upper panel] ), and similar responses
were observed in eggs treated with 50 µM 2-APB (Figure 2-11. lower panel); although,
[Ca2+]i levels seemed to return to baseline in a protracted manner, probably due to partial
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activation of TRPV3 channels on the PM by 2-APB. Thus, at the concentration tested, 2APB does not affect IP3R1 function in mouse eggs.

2.3 Discussion
Ca2+ signaling plays a pivotal role in many physiological processes including
fertilization and early embryo development. Increases in [Ca2+]i induce egg activation in
all animals studied to date, and these increases are mostly induced by fertilization and
sperm entry (6), but they can also be induced by mechanical stimulation (139). In
mammals, the fertilization Ca2+ signal last for several hours and the number of
oscillations and/or overall magnitude of the Ca2+ increases is directly related with
successful completion of all events of egg activation and embryo development to term
(59, 140). Extracellular Ca2+ influences the frequency and magnitude of the [Ca2+]i
responses (7) and is required for complete egg activation (8). Therefore, detailed study of
the Ca2+ entry pathways is essential to better understand the Ca2+ dynamics during
maturation and fertilization. We examined the contribution of a TRP channel to Ca2+
influx in mouse oocytes and eggs during maturation and fertilization. Using voltage
clamp and Ca2+ imaging measurements of WT and V3-KO mouse oocytes, we show that
TRPV3 becomes the major Ca2+ entry pathway in these cells as they mature. Ca2+
permeation via TRPV3, as induced by temperature elevation, and the TRPV3 agonists 2APB and carvacrol, was confirmed using TRPV3 knockout mice. Notably, TRPV3
channels are the major mediators of SrCl2 influx during strontium-induced activation in
mouse eggs. SrCl2 failed to induce oscillations or egg activation in TRPV3-null eggs. In
line with this, we have shown functional expression of the TRPV3 channel during
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maturation, with initiation of expression coinciding with resumption of meiosis (48).
TRPV3 channels are consequently able to mediate Ca2+ influx in mouse eggs and its
specific activation provokes Ca2+ influx capable of inducing parthenogenetic egg
activation. Here, we examined the localization and functional activity of the TRPV3
channel using gain- and loss-of-function approaches. Besides confirming the direct
stimulation of TRPV3 by 2-APB, we show it is a useful tool for further studies related
with Ca2+ channels expression and function in oocytes and eggs, as it does not affect the
function of IP3R1. Using fluorescence and Ca2+ imaging assays we show TRPV3
channels functionally interact with the actin cytoskeleton, and our results suggest other
channels involved in Ca2+ influx during maturation and fertilization may have similar
associations with the cytoskeleton. Future studies should address this possible
association. Also, given the sensitivity of TRPV3 channels to 2-APB, we propose future
experiments to elucidate the channels underlying fertilization-induced influx should be
performed in TrpV3 knock-down or TrpV3-KO oocytes and to avoid the confounding
effects of native TRPV3 channels, which are not required for sperm-induced [Ca2+]i
responses.
The small T-type, CaV3.2, currents in eggs does not appear to be necessary or
sufficient for Ca2+ oscillations. In any case, the normally depolarized egg membrane
potential ensures that they are primarily inactivated (20, 141). Thus, Cav channels would
most likely be important during an acute depolarizing stimulus, such as fertilization in
some species (142). Interestingly, commonly used Cav1(L-type) and Cav3 (T-type)
channel-blocking drugs are not known to be associated with human female infertility.
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Another potential source of Ca2+ entry, CRAC currents, might be active at the GV
stage of mouse oocytes, but their function decreases as maturation progresses (119).
Expression of Stim1 and Orai1 was detected in mouse oocytes and eggs (119), but to
date, no Stim1 or Orai1subtype female heterozygous or KO mice are reported to be
subfertile. Because Orai1-/- and Stim1-/- mice die prenatally, tissue- and age specific
genetic deletion would clarify this issue. Direct measurements of CRAC current under
voltage clamp would likely clear up these inconsistencies, but the size of eggs makes this
task difficult due to the size of background currents. In our studies, if CRAC currents are
present, they are ≤ 3 pA/pF (in 20 mM [Ca2+]e), but still large enough to be significant in
maintaining cytoplasmic and ER levels. We found that addition of a specific CRAC
(Orai1, Orai3) channel blocker during in vitro maturation of Het-V3 and V3-KO oocytes
did not affect germinal vesicle breakdown (GVBD); although, we did observe a slight
decrease in the percentage of polar body extrusion in both groups. Further experiments,
such as tissue-specific deletion of Orai subunits, are necessary to clarify the function of
CRAC channels during maturation.

2.3.1 Functional expression of TRPV3 channels during mouse oocyte maturation
At the germinal vesicle stage of oocyte development, TRPV3 currents were
undetectable, and consistent with this observation, conditions that activate TRPV3 fail to
induce Ca2+ influx. By the MI stage, however, small TRPV3 currents were recorded, and
these became significantly larger (in both net amplitude and density) in MII oocytes.
Thus, during maturation, increases in TRPV3 functional expression coincide with meiotic
progression during maturation. [Ca2+]e is required for progression beyond GVBD during
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oocyte maturation (14); without [Ca2+]e, the formation of the polar body is inhibited and
oocytes fail to progress past MI (143). In vivo, the immature GV stage oocyte maintains
direct communication with the surrounding cumulus and granulosa cells through gap
junctions, permitting heterologous metabolic and electrical coupling (127). However,
spontaneous Ca2+ oscillations recorded in GV stage oocytes are not dependent on the
surrounding follicle cells (144).
Although TRPV3 currents coincide with meiotic progression during maturation, the
TRPV3 channel function is not required for this process. The striking fact is that V3-KO
female mice have normal fertility and number of offspring to skin and hair rather than
mating or reproduction. Constitutively active TRPV3 mutations cause hair loss and
increase susceptibility to dermatitis and inflammatory skin lesions in rodents (145, 146),
although without apparent defects in female fertility. The Olmsted syndrome, a rare
human congenital disorder producing palmoplantar keratoderma, alopecia, and severe
itching, is associated with TRPV3 gain-of function mutations. However, it is unclear
whether female fertility is affected.

2.3.2 Stimulation of TRPV3 channels leads to egg activation
Activation of TRPV3 by carvacrol and 2-APB induces Ca2+ entry, which can
parthenogenetically activate eggs. Treatment with Ca2+ ionophores such as Ionomycin or
A213187 can result in embryos with decreased or impaired developmental competence.
The long-term ramifications on offspring are unknown (147), even though these
manipulations are used in patients who have low fertilization potential (148, 149). Thus,
the understanding of TRPV3 expression and function in human eggs may be an
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opportunity to improve artificial oocyte activation (AOA) via specific activation of
TRPV3 channels rather than the use of nonspecific ionophores.

2.3.3 Sr2+ induced egg activation and TRPV3 channels
Strontium induces egg activation by promoting oscillations in [Ca2+]i/[Sr2+], perhaps
by sensitizing the egg IP3R1 receptors. These SrCl2-induced calcium oscillations are
distinct from those provoked by the sperm (or by adenophostin, a nonhydrolyzable
agonist of the IP3R) and do not induce downregulation of the IP3R (150, 151). The
mechanism or Sr2+ gating of the IP3R1 is thus the TRPV3 channel, because it mediates
Sr2+ influx into rodent eggs. It has been suggested that Sr2+ could sensitize IP3Rs and
facilitate Ca2+ oscillations, perhaps by substituting for Ca2+ in the potentiation of IP3Rs
(152, 153). Strontium-induced egg activation is mediated by CaMKIIγ, as CaMKIIγ-/eggs failed to respond to Sr2+ treatment, likely due to a failure to resume meiosis II (154).
The fact that V3-KO eggs do not to respond to Sr2+ is clear evidence that under the
conditions in which Sr2+ -induced activation was measured (37°C, 10 mM SrCl2 in the
extracellular media, ~10 µM [Ca]), TRPV3 is required for measurable strontium
permeation. This does not mean that TRPV3 is the only strontium-permeable channel in
the egg plasma membrane. In fact, Cav channels present in the egg plasma membrane are
permeable to Sr2+ as shown by Hirano et al. (155), but Cav3 channels are largely
inactivated at the eggs’ resting membrane potentials. Because the egg membrane
potential remains stable at potentials in which Cavs are inactivated (23), we did not
observe measurable Sr2+ permeation via Cav, positioning TRPV3 as the major mechanism
for Sr2+ -induced egg activation in mice.
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2.3.4 Regulation and function of TRPV3 channels in mouse oocytes and eggs
Muscarinic receptors couple to the Gq/11 proteins in mouse eggs activate PLCβ (156)
and initiate PIP2 hydrolysis. This, in turn, generates IP3 and the PKC activator,
diacylglycerol (157). Muscarinic agonists induce membrane potential changes (158) and
a series of small [Ca2+]i oscillations in mouse eggs (159). Stimulation of PKC activity
greatly enhances the frequency of these oscillations (160). These same pathways also
modify TRPV3 channels: in somatic cells, carbachol (161), diacylglycerol, phorbol-12myristate-13-acetate, and PLC-coupled receptor-catalyzed PIP2 hydrolysis (162) all
modulate TRPV3 activity. Ca2+, via calmodulin, also activates CaMKII to modulate
oscillatory changes during fertilization (163) and govern exit from MII (164).
Ca2+/calmodulin initially inhibits TRPV3 activity, perhaps explaining sensitization of
TRPV3 to repetitive stimulation by mediating Ca2+-dependent initial channel inhibition
(165). In summary, there is good evidence that PLC activation regulates both oocyte and
egg TRPV3 and [Ca2+]i.
The male-specific PLCz, which more effectively generates PIP2 production in eggs, is
likely to be the upstream activator of TRPV3 (129). Accordingly, we expect that PLCz
overexpression would potentiate endogenous egg TRPV3 current. In spite of the
expression of TRPV3 in MII mouse eggs and its predicted nearly constitutive function at
37°C, TRPV3-mediated Ca2+ influx is seemingly dispensable for maintaining PLCzinduced [Ca2+]i oscillations or for fertility, because V3-KO females show normal
oscillatory responses in eggs and after fertilization.
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What is the function of TRPV3 in oocytes and eggs? One possibility is that TRPV3
channels constitutively conduct low levels of Ca2+ to maintain Ca2+ homeostasis.
Nevertheless, given the importance of these functions, eggs may have a redundant system
that may explain the unchanged oscillation pattern and fertility in V3-KO eggs. It is
probable that an unknown G protein receptor may be activated to induce PLCβ activation
and modulate TRPV3 activity. Less probable, but more intriguing, is that highly
temperature-sensitive TRPV3 may function to “reawaken” egg maturation/activation in
mammals that significantly lower their body temperatures during hibernation, and that
TRPV3 is thus not functionally relevant in mammals that do not hibernate. Increasing
ambient temperatures above 32°C would increase TRPV3 activity and prime progression
to MII. Finally, it is possible that there are unknown endogenous direct activators of
oocyte and egg TRPV3. Future studies will examine the expression of TRPV3 in other
species, such as humans, as well as the regulation of TRPV3 function.

2.3.5 2-APB activates TRPV3 channels without altering IP3R1 function in mouse
oocytes.
The actions of 2-APB on Ca2+ channels are both stimulatory and inhibitory. Its main
agonist activity towards channels of the TRP channel family has been associated with the
closely related members of the vanilloid subgroup (TRPV1, 2 and 3. (116)). 2-APB also
potentiates TRPM6 and has a bimodal action on TRPM7, with high micromolar
concentrations inhibiting TRPM7, whereas concentrations greater than 1 mM potentiating
TRPM7 currents (166). In addition, low concentration of 2-APB were shown to
potentiate ORAI1 and activate ORAI3 (114), which are the proteins that constitute the
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ion channels of the CRAC or SOCE current, and whose expression has been reported in
mouse eggs (119).
In light of the broad actions of 2-APB, it is necessary to identify the channel(s)
targeted by it in oocytes and eggs. Using electrophysiology and null mice, we have
shown that TRPV3 was functional in mouse oocytes and eggs and it was responsible for
the action of 2-APB (48). Here, we extended those results by showing that expression of
TRPV3 in GV oocytes, which lack endogenous TRPV3 on the PM, confers
responsiveness to 2-APB, confirming the specificity of the channel as the target of 2APB. We also show the response to 2-APB depends on extracellular Ca2+, which is
consistent with findings showing that eggs incubated in its presence at 37 °C undergoes
parthenogenetic activation.
The purported actions of 2-APB are not limited to targets on PM channels, but it has
also been described to target intracellular molecules and channels. In fact, 2-APB was
first investigated as an inhibitor of IP3R1 (112). IP3R1 plays a crucial role in fertilization,
and specific antibodies to it blocked [Ca2+]i responses associated with sperm entry and
egg activation (60). While the actions of 2-APB on IP3R1 have not been investigated in
mouse oocytes and eggs, addition of 2-APB was shown to block fertilization-induced
oscillations in eggs from TrpV3-KO mice. The possibility that results could be due to
inhibition of IP3R1 cannot be ruled out. Our results show that this is not the case, as 2APB not only did not abrogate Ca2+ release induced by cIP3, but actually increased it,
which is possibly due to activation of some TRPV3 channels on the PM by 2-APB. Thus,
our data show that the main action of 2-APB on WT eggs is on TRPV3 channels where it
promotes Ca2+ influx. Importantly, given that 2-APB behaves as a channel inhibitor in
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eggs of the TrpV3-KO mice (48), it could be a very useful tool to identify the channels
that underlie the sperm-induced oscillations in mouse eggs.

2.3.6 Actin microfilaments and functional expression of TRPV3 channels
The physiological regulation and natural agonists of TRPV3 channels are not well
characterized (51); although, a few interacting partners are known, including calmodulin
(165), epidermal growth factor receptor (EGFR) (167), and TRPV1, which reportedly
forms heteromeric channels with TRPV3 (50). The cytoskeleton, especially actin, has
also been shown to interact and modulate the function of members of the TRP family
(134), and of other ion channels (120). Related to TRPV3 activity is the impaired
function of TRPV4 caused by addition of LatA, which affects the regulation of cell
volume (133). In mouse oocytes and eggs, the role of actin on PM channels has not yet
been explored. Research shows evidence of an association between actin organization
and Ca2+ homeostasis, as in starfish oocytes, LatA induced Ca2+ mobilization that
resulted in fast discharge of cortical granules similar to responses caused by fertilization
(168). In rat basophilic leukemia (RBL) cells, [Ca2+]i oscillations and IP3 synthesis are
directly associated with oscillations of cortical actin polymerization and cycles of vesicle
secretion (169). Our results in mouse eggs demonstrate TRPV3 channels and the actin
cytoskeleton are also interconnected, as depolymerization of actin reduced the recycling
of TRPV3 channels to the PM, which was evidenced by the loss of TRPV3 expression on
the PM and increased presence in the cytoplasm. Remarkably, where the effects of LatA
on actin organization became evident after a few hours of exposure to the drug, the effect
of LatA on TRPV3 responses to 2-APB or Sr2+oscillations was faster, approximately
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within 20 minutes of addition of LatA. We speculate this “fast” action of LatA might be
due to altered permeability of the channels caused by disruption of the cortical
microfilaments, which also reportedly occurs for SOCE, whose current is impaired by
disruption of the actin cortical layer subjacent to the PM without substantial breakdown
of the actin cytoskeleton (170). It is unknown whether the function of TRPV3 channels in
mouse eggs is regulated by other factors known to regulate these channels in somatic
cells, such as hydrolysis of PIP2 (162) or by the polymerization-depolymerization cycles
of cortical actin. Future studies should investigate this possibility along with the prospect
that actin also regulates the activity of other channels involved in Ca2+ influx during
maturation and fertilization.!!
!
2.3.7 TRPV3 responsiveness to 2-APB and Sr2+
It is known that TRPV3 mediates Sr2+ influx in unfertilized eggs and as shown here, it
is also the target of the stimulatory effects of 2-APB on Ca2+ influx in these cells (48). It
is noteworthy that only in rodent eggs- mice and rats- Sr2+ exposure causes oscillations
and egg activation (136). Moreover, exposure of bovine eggs to Sr2+ does not result in
egg activation or oscillations. Further, evidence in the literature suggests that Sr2+ might
not be a reliable parthenogenetic agent in humans, which implies that these cells also do
not display oscillations in response to Sr2+ treatment (171). Therefore, there exists the
possibility that the response to 2-APB treatment and the ability of Sr2+ to initiate
oscillations are associated. The residues that mediate the responsiveness of TRPV3 to 2APB are known (116) and are well conserved among mammals, which suggest that this
might not underlie the differences between oocytes of different species. Therefore, it is
possible that different residues determine ability to conduct Sr2+; although, this seems
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very unlikely considering that the pore region within related channels (same family) is, in
general, conserved (172). Alternatively, not all mammalian oocytes might express
TRPV3 channels, which would prevent Sr2+ influx altogether, as well as responses to 2APB. Lastly, despite Sr2+ influx, IP3R1s in those species might be less sensitive to the
stimulatory effects of Sr2+ and therefore might not be capable of promoting additional
Ca2+ release to induce a whole-cell Ca2+ increase. Future studies should determine how
the responsiveness to 2-APB and Sr2+ influx are associated, as it might lead to the
development of better parthenogenetic agents. I would like to attempt a rescue
experiment using V3-KO mice. I plan to inject TRPV3 cRNA into GV oocytes of V3-KO
mice, and I will induce Sr2+ activation and 2-APB mediated Ca2+ influx 12 to 24 hr after
the injection of the cRNA.
We have already published some of these data in Cell Reports (2013), and other data
were accepted to publish in Cell Calcium (2015).

2.4!Materials!and!Methods!
!
2.4.1 Animal care and welfare
Animals used for gamete collections for this study were handled according to the
National Research Council’s Animal Care and Welfare guidelines. The Institutional
Animal Care and Used Committee at the University of Massachusetts approved these
procedures.
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2.4.2 Collection of mouse oocytes
GV oocytes were collected from the ovaries of 6- to 10-week-old CD-1 female mice
44–46 hr after injection of 5 IU of pregnant mare serum gonadotropin (PMSG; Sigma).
Cumulus intact GV oocytes were recovered in a HEPES–buffered Tyrode's lactate
solution (TL-HEPES) containing 5% heat-treated fetal calf serum (FCS; Gibco) and 100
µM isobutyl-I-methylxanthine (IBMX). Cumulus cells were removed by repetitive
pipetting and denuded oocytes were matured in vitro for 12–14 hr in IBMX-free Chatot,
Ziomek, and Bavister (CZB) [Chatot CL J reprod fertilization 1989] media that were
supplemented with 3 mg/ml bovine serum albumin (BSA) or 0.1% polyvinyl alcohol
(PVA; Sigma, St Louis, MO) under mineral oil at 37°C in a humidified atmosphere of
5% CO2. MII oocytes were collected from the oviducts 12–14 hr after administration of 5
IU of human chorionic gonadotropin (hCG), which was administered 46–48 hr after
PMSG. Cumulus cells were removed with 0.1% bovine testes hyaluronidase (Sigma).

2.4.3 TRPV3 plasmid and dsRNA preparation
Mouse TrpV3 (mTrpV3 cDNA) construct kindly provided by the lab of Dr. D Clapham
(Boston Children’s Hospital-Harvard Medical School). TrpV3 was subcloned into a
pcDNA6B/his-myc B vector between the XhoI and AgeI restriction sites. To determine
the subcellular distribution of the protein in oocytes and eggs, the sequence encoding
TrpV3 was tagged on the N-terminal end with the sequence encoding for the fluorescence
protein Ruby. Double stranded RNA (dsRNA) oligonucleotides against the TrpV3 gene
was synthesized by the MEGAclear Kit (or Cell to cDNA Kit). DNA fragments of
approximately 520 bp in length containing coding sequences for the protein to be
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“knocked down” were amplified using PCR. Each PCR primer will contain a 5’ T7 RNA
polymerase-binding site (TAA TAC GAC TCA CTA TAG GG) preceding the targeted
sequences. The sequences used for primer construction are as follows: TrpV3, GenBank
accession no. NM145099, sense-primer: CATCA CCCTG ACCCT TGTCT; antisenseprimer: GCTGA AGCTG CCATA GGAAC. A plasmid target to the fluorescent protein
Venus was used as a control (T7 Venus 5F’: TAA TAC GAC TCA CTA TAG GG
GACGT AAACG GCCAC AAGTT, T7 Venus 3R’: CCC TAT AGT GAG TCG TAT
TA GGATC TTGAA GTTGG CCTTG). The PCR products were purified using the
MEGAclear kit (Ambion). Purified PCR products were used as templates by a
MEGASCRIPT T7 transcription kit (Ambion) to produce dsRNA (173). The dsRNA
products were ethanol-precipitated and resuspended in water. The dsRNAs were annealed
by incubation at 65 °C for 30 min followed by slow cooling to room temperature. The
concentrations of dsRNAs was adjusted to 1-2 µg/µl, with aliquots stored at -80 °C.

2.4.4 TRPV3KO mice
These mice were generated in the lab of Dr. David Clapham and details are published
in Cell Reports eggs (48).

2.4.5 Microinjections
Microinjections were performed as described previously (174). dsRNAs or cRNA were
centrifuged, and the top 1-2 µl. used to prepare micro drops from which glass
micropipettes will be loaded by aspiration. dsRNAs or cRNA were delivered into oocytes
by pneumatic pressure (PLI-100 picoinjector, Harvard Apparatus, Cambridge, MA). Each
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oocyte was received 5 - 10 pl, which is approximately 1- 3% of the total volume of the
egg. Injected GV oocytes were allowed for maximal translation up to 8 hr in CZB in
medium supplemented with IBMX, after which IBMX was washed off to allow for
resumption of maturation for 12 hr. For downregulation of TrpV3 mRNA, dsRNAs were
injected at the GV stage and held there in IBMX for 8 hr, after which maturation was
allowed to resume. Evaluation of mRNA degradation was performed using the Cell to
cDNA kit (Ambion), after which relative expression levels of transcripts were compared.

2.4.6 Parthenogenetic egg activation
For TRPV3-mediated egg activation, eggs were incubated at 37°C for 10 min in 50 µM
Carvacrol in CZB medium or for 30 min in 200 µM 2-APB in modified Krebs-Ringer
bicarbonate medium. In both cases, the media was FCS-free 0.1% PVA (poly-vinyl
alcohol, Sigma). In studies using MII eggs, activation was induced by exposure to 2.5 µM
Ionomycin (A.G. Scientific) for 5 min in Ca2+-free CZB media followed by incubation
for 4 hr in CZB (0.1% PVA) supplemented with cycloheximide (CHX, 20 µg/ml, EMD
Biosciences). All procedures were in humidified 5% CO2 at 37°C. For Sr2+ activation,
eggs were incubated for 2 hr in Ca2+ -free CZB medium supplemented with 10 mM
SrCl2. Eggs were then washed and transferred to HTF medium and cultured to the 2-cell
stage.
Eggs were evaluated for signs of activation 5 and 24 hr after treatment under phase
contrast microscopy. Activated eggs were classified according to the following criteria:
(1) PN group, consisted of zygotes forming a single PN with first and second polar bodies
(5 hr post treatment); (2) cleaved group, eggs undergoing immediate cleavage after 24 hr.
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Eggs without second polar bodies, PN formation, or those failing to cleave were
considered as un-activated MII eggs. Fragmented eggs were excluded from analysis.

2.4.7 [Ca2+]i measurements
[Ca2+]i monitoring was performed as previously described (174). [Ca2+]i was measured
using the Ca2+ sensitive dyes Fura-2-acetoxymethyl ester (Fura 2-AM, Molecular Probes;
Invitrogen) or Fluo-4-AM (Invitrogen). Oocytes were loaded with 1.25 µM Fura-2AM
(Fluo) supplemented with 0.02% pluronic acid (Molecular Probes) for 20 min at room
temperature. Oocytes were placed in micro-drops of TL-HEPES on a monitoring glass
bottom dish (Mat-Tek Corp.) under mineral oil. Eggs were monitored simultaneously
using an inverted microscope (Nikon) outfitted with fluorescence measurement
capabilities. Fura 2-AM were excited between 340 nm and 380 nm by a filter wheel (Ludl
Electronic Products Ltd.), and fluorescence was captured every 20 s. To estimate TRPV3
channel protein functional expression, oocytes were treated with 50, 100, 200 µM 2-APB,
and Ca2+ responses monitored in Ca2+ or in Ca2+ free TL-HEPES.
To test for IP3-induced Ca2+ release, 0.25 mM Caged-IP3 (cIP3; Molecular Probes) was
injected into MII oocytes. Injected oocytes were loaded with 1 µM Fluo-4AM for 20 min
and photolysis were performed 1-2 hr after microinjection of cIP3 in Ca2+ free TLHEPES +EGTA. cIP3 photolysis was released by pulses of 360 nm wavelength UV light
provided using a 75W Xenon arc lamp, which also produce the 488 nm wavelength
required to excite Fluo-4. Emitted light above 510 nm were collected by a cooled
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Photometrics SenSys CCD camera (Roper Scientific). Acquisition of fluorescence ratios
will be analyzed by SimplePCI software 5.2.1 (Hamamatsu) (118).

2.4.8 Preparation of pharmacological agents
Latrunculin A (Lat-A), Cyclohexamide (CHX), Colcemid (COL), and 2Aminoethoxydiphenyl borate (2-APB) were from Calbiochem. The stock solutions were
dissolved in dimethyl sulfoxide (DMSO; Sigma) and further diluted in CZB or TLHEPES medium to their final concentration (Lat-A; 5 µM, CHX; 10 µg/ml, Col; 5 µM,
and 2-APB; 200 µM).

2.4.9 Confocal microscope imaging
Live-cell imaging of oocytes/eggs expressing fluorescent-tagged proteins were
performed with a confocal laser-scanning microscope (LSM 510 META, Carl Zeiss
Microimaging Inc., Germany) using a 63 X 1.4 NA oil-immersion objective lens, and as
previously performed in the lab (14). Images were acquired with LSM software (Carl
Zeiss Microimaging Inc., Germany). Oocyte/eggs expressing TRPV3 tagged with Ruby
fluorescent protein were collected at variable times of maturation and attached to glass
bottom dishes while incubated in HCZB medium. The measurement of fluorescence
intensity was analyzed using ImageJ64.

2.4.10 Electrophysiology
Whole-cell currents were measured at 22°C - 24°C using an Axopatch 200B amplifier
digitized at 20 kHz (Digidata 1320A) and filtered at 5 kHz. Electrophysiology recordings
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were performed on the same day of egg isolation up to 8 hr post surgery. Eggs were
maintained in human tubal fluid medium (HTF, EMD Millipore) at 37°C and 5% Co2.
For temperature ramps, the perfusate was heated using a TC-324B temperature controller
and SH-27B solution heater (Warner Instrument Corporation). Data were analyzed using
Clampfit (Molecular Devices) and Origin 7.0 (Origin Lab). Pipettes of 1-3 MΩ resistance
were made from glass capillaries (593600, A-M Systems). Series resistance was
compensated by 60%-80%. The intracellular solution contained 152 mM Csmethanesulfonate, 1 mM Cs-BAPTA, 10 mM HEPES, 2 mM Mg ATP, 8 mM NaCl, and
0.3 mM NaGTP (pH 7.3-7.4). The external solution contained 125 mM NaCl, 6 mM KCl,
20 mM CaCl2 1.2 mM MgCl2, and 20 mM HEPES-NaOH (pH 7.3-7.4). The response to
2-aminoethoxydiphenyl borate (2-APB, Sigma) was measured in an external solution
containing 140 mM NaCl, 10 mM

HEPES, 10 mM Glucose, 4 mM KCl, 1 mM MgCl2,

and 2 mM CaCl2. In order to avoid chloride currents (Qu and Hertzell, 2000), a solution
of Na-gluconate was used in the temperature response experiments and in the Sr2+
permeability experiments. The osmolality of all solutions was 290-300 mOsm. All
voltages were corrected for measured junction potentials present between the internal and
external solution before seal formation. TRPV3 currents were activated by voltage ramps
from -100 mV to 100 mV (600 ms, every 2 s), in the presence of 2-APB or temperature
ramps. The holding potential (HP) was -80 mV. For Sr2+ permeability recordings and to
avoid T-type voltage gated Ca2+ channels, ramps are from +100 mV to -100 mV with a
HP of 0 mV.

2.4.11 Statistical Analysis
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Data collected in these studies were used for evaluation of statistical significance. The
prism software (GraphPad Software) was used to perform statistical comparisons using
student’s t-test, or ANOVA, or the appropriate test for the data under analysis. All data
were presented as mean ± SEM. Significant differences were considered at P values
<0.05.
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CHAPTER 3
THE ROLES OF PLCZ1 IN HUMAN FERTILITY
!
Summary
In mammals, sperm-oocyte fusion initiates Ca2+ oscillations leading to a series of
events called oocyte activation, which is the first stage of embryo development. Ca2+
signaling is elicited by the delivery of an oocyte-activating factor by the sperm. A spermspecific PLCZ1 has emerged as the likely candidate to induce oocyte activation.
Recently, PAWP, a sperm-born tryptophan domain-binding protein coded by WBP2NL,
was proposed to serve the same purpose. The first part of this study was conducted to
determine if expression of the testis-specific PLCZ1 correlated with low success or
fertilization failure after ICSI in patients with normal parameters after standard semen
analysis (SA). Standard semen analysis was performed to determine sperm parameters in
male partners, whereas females were evaluated for antral follicle counts (AFC), day 3
FSH levels and peak estradiol (E2) levels. The presence of PLCZ1 in sperm was
ascertained using western blotting and immunofluorescence (IF) analysis. The ability of
sperm to initiate changes in the intracellular concentrations of [Ca2+]i, which is
characteristic of mammalian sperm, was performed after injection of human sperm into
mouse eggs loaded with the Ca2+ sensitive dye fura-2 AM. Male partners of couples with
failed or low success ICSI fertilization but with normal SA parameters showed low
expression levels of PLCZ1 as determined by western blotting and reduced fluorescent
signal during IF studies. In addition, fewer of these males’ sperm showed PLCZ1
expression and were able to initiate robust [Ca2+]i oscillations upon injection into eggs. In
the second part of this study, we examined two infertile brothers exhibiting largely
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normal SA parameters, including sperm morphology, but complete fertilization failure
after intra cytoplasmic sperm injection (ICSI). Whole exomic sequencing evidenced a
missense homozygous mutation in PLCZ1, converting Ile 489 into Phe (Ile489Phe). We
showed that the mutation is deleterious, leading to absence of the protein in sperm.
Mislocalization of the protein when injected in mouse GV and MII oocytes produced
highly abnormal Ca2+ transients and early embryonic arrest. Altogether these alterations
are consistent with our patients’ sperm inability to induce oocyte activation and initiate
embryo development. In contrast, no mutations were identified in WBP2NL and PAWP
presented normal expression and localization. Overall we demonstrate in humans that the
absence of PLCZ1 alone is sufficient to prevent oocyte activation irrespective of the
presence of PAWP. Additionally, it is the first mutation located in the C2 domain of
PLCZ1, a domain involved in targeting proteins to cell membranes, opening the door for
structure function studies to define the conserved amino acids on the β1 strand of the C2
domain that might regulate the selectivity of PLCZ1 for its lipid substrate(s).
3.1 Introduction
Fertilization causes eggs to leave their meiotic arrest and initiate embryo development.
The universal signal whereby the sperm induces the initiation of development is an
increase in the intracellular concentration of free calcium [Ca2+]i, which was demonstrated
to be a sufficient and necessary stimulus to trigger oocyte activation and embryo
development in all species studied to date (175). In mammals, this Ca2+ signal unfolds in
a manner of repeated short-lived rises, which are also known as [Ca2+]i oscillations, that
last in excess of 4 hr in the mouse and as long as 20 hr in other species including humans
(11). It is thought that activation of the phosphoinositide pathway (PI) in the egg by a
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sperm-derived phospholipase C (PLC) enzyme underlies the oscillations by hydrolyzing
phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol triphosphate (IP3) and
diacylglycerol (DAG). IP3 promotes Ca2+ release by binding to the inositol 1,4,5triphosphate receptors (IP3R1) located in the endoplasmic reticulum (ER) membrane,
which is the Ca2+ store of the cell (176, 177). The [Ca2+]i oscillations induce the exit from
the meiotic arrest, the metaphase II stage (MII), and the initiation of the events of
activation that render eggs into zygotes (140, 164). Despite this pivotal role, a persistent
question has been by what mechanism does the sperm initiate and sustain the [Ca2+]i
oscillations?
Current evidence suggests that after fusion the sperm delivers into the egg’s cytosol a
factor that is responsible for triggering [Ca2+]i oscillations. It is thought this factor is
capable of activating the PI pathway and induces production of IP3. Evidence suggests
that the factor is a male-specific PLCZ1, which was first discovered following a screen
for expression of sequence tags related to PLCs in testis (19). It was subsequently shown
that expression of cRNAs encoding for PLCZ1 in eggs initiated oscillations reminiscent
of those induced by normal fertilization (19, 174). Additional studies demonstrated
expression of PLCZ1 in the testes of other mammals and PLCZ1 cRNAs were able to
induce oscillations in eggs of homologous and heterologous species including human
PLCZ1 into human eggs (19, 62). Further, injection of sperm extracts depleted of PLCZ1
failed to initiate oscillations (19, 174). Despite this evidence, demonstration of the
unique and primary role of PLCZ1 on mammalian fertilization needs confirmation from
genetic models where the gene is purposely eliminated. However, the inability thus far to
obtain a PLCZ1 KO animal model capable of producing mature sperm has prevented
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assigning to this molecule the exclusive role for oocyte activation, while leaving open the
possibility that other sperm factor may be required (178).
Towards that end, PAWP has been proposed as an alternative or complementary
pathway for eggs activation based on findings that injection of recombinant PAWP
induced oscillations comparable to those of fertilization (105). Nevertheless, attempts to
replicate those studies in mouse eggs failed (108, 109) and no defects, including egg
activation, were reported for sperm of PAWP null mice (110). The role of PAWP remains
thus uncertain, although the possibility that a human oocyte specific factor is needed was
not ruled out. Indeed, numerous studies have shown that testis and reproductive tissues
evolve faster than other tissues leading to noticeable differences between species (111).
Human clinical studies have proven a valuable asset to gain insight into the role of
PLCZ1 in fertilization and fertility. For example, approximately 1-3% of ICSI procedures
result in fertilization failure and nearly 80% of these failures display “unsuccessful egg
activation” (179, 180). Examination of patients with repeated ICSI failure revealed that in
the majority of cases their sperm were unable to consistently initiate [Ca2+]i responses
and showed low expression levels of PLCZ1 (98). Subsequent studies extended the
association between PLCZ1 and infertility, as it was found that one case of failed ICSI
was linked to point mutations in the catalytic domains of PLCZ1, which undermined the
ability of the enzyme to initiate robust oscillations (99, 181). Interestingly, in the initial
studies, most of the PLCZ1-associated defects appeared linked to severe defects of sperm
morphology, especially globozoospermia, which is characterized by round-headed sperm
that lack most of the acrosomal content (148). Nevertheless, in our present observations
we noted a few cases of ICSI failure in patients with grossly normal semen analysis (SA)
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including normal morphology. In the first part of this study we examined the association
of PLZ1 expression and ICSI failure in patients with normal SA parameters. We also
examined whether the sperm of these patients showed uniform or inconsistent ability to
initiate [Ca2+]i oscillations. We found that the sperm of patients with normal SA but failed
fertilization (FF) after ICSI expressed low levels of PLCZ1 and had dissimilar [Ca2+]iinducing oscillatory ability; a minority of sperm are capable of initiating robust
responses, whereas the majority of sperm are capable of only inducing mediocre or no
responses at all. Invariably, in these sperm, the equatorial distribution of PLCZ1 was
compromised. Thus, our results show in cases of ICSI failure with normal SA values only
a few sperm are capable of initiating robust [Ca2+]i responses and their selection will
likely yield better fertilization outcomes. In the second part of the study, we examined
two infertile brothers showing complete fertilization failure after ICSI. Exome
sequencing enabled us to find a missense homozygous mutation in PLCZ1, converting Ile
489 into Phe, and structure-functional models reveal a conformational change that might
affect binding to substrate(s). Using Western blotting (WB), immunofluorescence (IF),
live fluorescence and Ca2+ imaging, we show that the mutation is deleterious, leading to
mislocalization of the protein, lower enzymatic activity and lower rates of oocyte
activation and embryo development. In contrast, no mutations were identified in
WBP2NL and PAWP showed normal expression and localization. Overall we
demonstrate in humans that the absence of PLCZ1 alone is sufficient to prevent oocyte
activation irrespective of PAWP. Moreover, it is the first mutation located in the C2
domain of the enzyme, an important domain targeting proteins to lipid membranes,
opening the door for better structure function analysis of PLCZ1 and of proteins that
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carry this domain.

3.2 Results
3.2.1 Clinical parameters of failed-fertilization (FF) ICSI patients
Four couples seeking infertility treatment at Baystate Medical Center during 20102012 (one couple was referred from the Fertility and Reproductive Health Center, UCLA,
CA) had either one or two failed ICSI cycles or low (<25%) fertilization after this
procedure. Baystate performs ~500 A.R.T cycles per year and therefore these three cases
represented approximately 1% of the patient population, which is in line with national
statistics for failed fertilization cases after ICSI (182). Table 1 summarizes the main
female clinical and SA parameters information regarding the couples under consideration.
Clinical information is also presented as a form of control from a contemporaneous
couple that underwent successful fertilization (SF) after ICSI and from another
contemporaneous

patient

with

abnormal

semen

parameters,

oligoasthenoteratozoospermia (OAT), which failed ICSI. Female clinical parameters are
limited to a few values indicative of their response to stimulation protocols, such as AFC,
peak E2 levels before day 10 of stimulation, day 3 FSH and number of eggs retrieved.
The obtained values were mostly unremarkable leading us to suspect the cause of
unsuccessful fertilization might be of male origin. Male parameters from SA examination
were also unremarkable, as parameters for FF1-FF3 patients were comparable to those of
the control patient SF1; sperm parameters for the OAT male were expected to be
abnormal. The only consistent and significant finding for FF1-FF3 patients was the low
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fertilization rates after ICSI, which given the known association between failed ICSI and
defects in PLCZ1 expression (98, 99), prompted us to examine the patients’ sperm for
PLCZ1 expression and localization as well as ability to initiate [Ca2+]i responses in
mouse eggs.

3.2.2 Morphology and [Ca2+]i-inducing oscillatory activity of sperm of FF patients
As previously discussed and as shown in Figure 3-1, the sperm of patients FF1, FF2
and FF3 displayed unremarkable morphology, meaning that it was similar to that
displayed by the sperm of a cohort control patient SF1, whereas the morphology of sperm
from the OAT patient was abnormal, showing a combination of pyriform heads and
amorphous shapes (Figure 3-1, OAT, left and right panels, respectively).
To elucidate whether these sperm with grossly normal sperm morphology but failed ICSI
showed reduced ability to initiate [Ca2+]i oscillations, we performed ICSI using the sperm
of each patient and mouse eggs as the recipient cells. While all spermatozoa from the
control patient initiated [Ca2+]i responses (13/13), only 50 to 70% of the FF patients’
sperm initiated responses (Figure 3-2). Importantly, while 8/13 sperm from the control
patient initiated the expected vigorous, +++, [Ca2+]i responses; only 1/8, 2/10 and 0/24
sperm from FF1, FF2, and FF3 patients, respectively, initiated this type of response. In
the case of the SF1 patient, the rest of the sperm initiated moderate, ++, responses,
whereas all the rest of FF1-3 sperm initiated moderate to low, ++, [Ca2+]i responses.
Expectedly, sperm from the OAT patient were only capable of initiating these moderate
to low [Ca2+]i responses (3/8; Figure 3-2). Altogether, the results show that whereas the
morphology of sperm associated with ICSI failure is highly variable, they share a defect
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to initiate robust [Ca2+]i oscillations. It is noteworthy nevertheless that a small minority
~10 to 20% of the sperm from patients that failed ICSI were still capable of initiating
robust [Ca2+]i responses in mouse eggs.

3.2.3 Expression and localization of PLCZ1 in the sperm of FF patients
To determine whether the low [Ca2+]i -oscillatory activity of FF patients correlated
with low expression levels of PLCZ1 and/or mislocalization of PLCZ1, we performed
western blotting and IF studies using a specific anti-PLCZ1 antibody. Immunoblot
studies revealed that all patients that repeatedly failed ICSI displayed reduced expression
of PLCZ1, which was especially noticeable in sperm from FF3 and OAT patients (Figure
3-3); it is worth noting that these two patients’ sperm were the only ones in the study
unable to initiate robust [Ca2+]i responses.
Examination of the localization of PLCZ1 in the same patients revealed that the majority
of SF, control, sperm (63%, 41/65) showed the expected equatorial localization
characteristic of PLCZ1 in human sperm (Figure 3-4) (98). The PLCZ1 signal was
detectable in only 25% (12/47) of FF1 sperm, 21% (18/86) of FF2 sperm and 12% (2/17)
of FF3 sperm. As expected, only 5% (2/36) of the OAT sperm showed PLCZ1 reactivity.
In addition, the intensity and distribution of PLCZ1 was highly abnormal in FF sperm
(Figure 3-4). For instance, while FF1 sperm displayed PLCZ1 distribution consistent with
its uniform equatorial localization, albeit of low intensity, PLCZ1 localization in FF2
sperm was arranged in discontinuous patches along the equatorial band, whereas in FF3
sperm the presence of PLCZ1 in the equatorial region was negligible, although some
reactivity was observed on the base of the head, which is denoted by an arrowhead.
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Sperm from the OAT patient, as expected, showed uncharacteristic distribution of PLCZ1
(Figure 3-4; bottom two rows).

3.2.4 Identification of a homozygous PLCZ1 mutation in two brothers with
recurrent oocyte activation failure
In the previous study, we did not perform genome analysis of the patients failing ICSI.
However, we did in the subsequent study, as we encounter infertility in two brothers.
Specifically, two Tunisian brothers and their respective wives sought medical advice
from infertility clinics in Tunis between 2008 and 2014. The brothers were born from
first cousin parents and have one fertile brother with children conceived spontaneously
and two fertile sisters. The brothers showed sperm parameters well above the low
reference limits set by the WHO guideline [World Health Organization, 2010]; even
although patient 1 (P1) had higher than normal number of sperm with acrosome defects
(Figure 3-5). To investigate this in more detail, we examined acrosome morphology using
an anti-acrosin antibody and found that the acrosome was absent in ~50% of sperm of
both brothers. The acrosomal abnormality found in the patients was most likely due to a
premature acrosome reaction and not to a lack of acrosome biogenesis because the shape
of sperm head was normal and not globozoospermic (Figure 3-6A). Finally, DNA quality
was assessed using three different methods: chromomycin A3 (CMA3), aniline blue (AB)
and terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridine triphosphate
(dUTP)-nick-end labeling (TUNEL), which allowed evaluation of DNA protamination,
histone content and DNA fragmentation, respectively. Although higher than in fertile
control men, the percentages of positive sperm were below 20% for all methods (Figure
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3-6B). Although these sperm parameters are compatible with spontaneous conception, the
clinical outcome following several ART procedures for both brothers was fertilization
failure. P1 had two unsuccessful attempts of artificial insemination and sperm from both
brothers was used subsequently for ICSI. In total, three ICSI cycles were carried out with
20 MII oocytes being injected; however, none of the oocytes displayed signs of activation
such as extrusion of the second polar body (Table 2). Since both brothers were married to
unrelated women we excluded the possibility of a female factor. We therefore proceeded
to whole exome sequencing to identify a possible genetic defect(s) that could explain the
observed fertilization failures. Given the parental consanguinity, we focused on
homozygous mutations. After exclusion of frequent variants only four common
homozygous variants were identified in both brothers (Figure 3-7A). Three variants,
located in EPS8, RP11- 021N1.1 and LKAAEAR1, had no expected deleterious effect.
The fourth variant was a missense mutation on PLCZ1, c.1465A>T located in exon 13,
changing an Ile at position 489 into a Phe (Ile489Phe) (Figure 3-8A). Given that PLCZ1
has been suggested to be necessary for oocyte activation in mammals, this mutation could
underlie the patients’ phenotype. The presence of the mutation was validated by Sanger
sequencing, which also found both affected brothers to be homozygous for the mutation,
whereas the 3rd, fertile brother was heterozygous for the same mutation (Figure 3-7B).
The c.1465A>T variant was absent from over 60,000 individuals described in the ExAC
database (http://exac.broadinstitute.org), which confirms it is not a polymorphism and
that missense variations occurring at this localization would likely cause negative
selection throughout evolution. We verified the conservation of the concerned amino acid
and found Ile489 to be well conserved throughout evolution (Figure 3-8B), suggesting
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that this mutation could be deleterious.

3.2.5 Deleterious effects of the identified mutation
To assess the impact of the mutation on protein expression, PLCZ1 expression and
localization were first studied on sperm from both patients. IF was performed with a
specific anti-human PLCZ1 polyclonal antibody. Whereas the sperm of fertile patients
showed a band of strong staining on the postacrosomal area and more diffuse staining
over the acrosome (Figure 3-8C1), there was no staining detectable in the sperm from the
patients, except for a few sperm showing a faint punctuate staining over the acrosome
(Figure 3-8C2), which suggested the mutant PLCZ1 was absent or present at a very low
concentration. Absence of PLCZ1 in the patients’ sperm was confirmed by Western
blotting, where a single band at the expected MW of PLCZ1 was noticeable in the control
lane, although there was no corresponding band in the patients’ lanes (Figure 3-8D)
despite loading similar number of sperm (Figure 3-8E). These results suggest that during
spermatogenesis Ile489Phe PLCZ1 displays defects in stability, trafficking and/or
anchoring. To examine these possibilities, cRNAs of human WT and Ile489Phe Venustagged PLCZ1s were first injected into mouse GV oocytes, which given their cell cycle
arrest, permit comparisons of protein distribution at the same stage of the cell cycle. WT
PLCZ1 exhibited a homogeneous distribution in the ooplasm, which partly co-localized
with the endoplasmic reticulum, which was marked by ER-DsRed (Figure 3-9A).
Conversely Ile489Phe PLCZ1 displayed an uneven distribution, characterized by large
patches near the nucleus and decreased peripheral localization; the distribution of the
patches did not overlap the distribution of the ER (Figure 3-9B). These results suggest
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that the mutation does not affect the stability of PLCZ1, although its trafficking and/or
anchoring ability appeared altered. To further test the later, we took advantage of a
property of mouse Plcz1 (mPlcz1) which, following pronuclear (PN) formation, is
translocated into the PN (90, 91). WT and Ile527Phe mPlcz1 cRNAs (the equivalent
mutation of Ile489Phe human PLCZ1 (hPLCZ1)) were injected into MII eggs, which
were activated by the oscillations initiated by the translated proteins. Following PN
formation, as expected, WT mPlcz1 accumulated in the PN. In contrast PN formation was
delayed by ~ 3 hr when the mutant Ile527Phe mPlcz1 was injected, presumably due to
lower oscillation frequency, and the mutant protein failed to localize to the PN (Figure 39C). These results suggest the mutation modifies PLCZ1’s anchoring and/or trafficking
properties in oocytes and zygotes, and these properties might be also altered during
spermatogenesis, which could explain the absence of Ile489Phe PLCZ1 in patients’
sperm.
We next assessed the enzymatic activity of the mutated human and mouse PLCZ1s, by
examining the Ca2+responses elicited by injection of their cRNAs in mouse eggs. WT
hPLCZ1 initiated high frequency oscillations in all injected eggs (Figure 3-10A); in
contrast, the activity of the mutated PLCZ1 was strongly decreased between 10 to 100fold (54%, n=17/31) or abolished (76%, n=14/31) (Figure 3-10B) and the activity of the
Ile489Phe hPLCZ1 was decreased irrespectively of the concentrations of cRNA injected
(Figure 3-10C). These results suggest that possible traces of hPLCZ1 may not be
sufficient to activate oocytes. To confirm this hypothesis, both WT and mutant cRNAs
were injected into mouse eggs, and rates of PN formation and cleavage to the 2-cell stage
were evaluated; Ile489Phe hPLCZ1 showed a greatly reduced ability to induced oocyte
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activation and zygotes failed to progress to the blastocyst stage (Figure 3-10D). Similar
results were obtained with mPlcz1, as Ca2+ responses triggered by mIle527Phe were
weaker than WT Plcz1, with a longer lag time, and reduced frequency (Figure 3-11AB),
which compromised pre-implantation embryo development (Figure 3-11CD).

3.2.6 Mutation alters the C2 domain
To assess the possible impact of the mutation on the structure of hPLCZ1, a 3D
structure of hPLCZ1 was modeled from the crystallographic structure of rPLCdelta1
(42% identity, 59% homology). The model shows that Ile489 is at the interface of the EFhand and C2 domains, and it appears too distant from the catalytic domain to directly
affect its function (Figure 3-12A). Using molecular dynamics simulations of the hPLCZ1
and hPLCZ1-Ile489Phe models, we observed that the larger size of Phe over Ile (203 vs
169 Å3) initially results in a displacement of its intradomain neighbors (Y582, F601,
Y603, and R487) by sculpting a more accommodating space, and second in establishing a
unique interdomain hydrophobic contact with I76 from the proximal EF-hand 2 helix
(Figure 3-12BC). The notable outcomes of these perturbations are the formation of an
aromatic-rich concave-like subsite capable of associating with lipophilic molecules or
protein surfaces (Figure 3-13) and a significant shift of the EF2 domain toward C2 (12.2
vs 10.7 Å for CαI76–CαI489 and CαI76– CαF489 distances, respectively), reinforced by
the newly formed H-bond between the newly displaced Y582 and Y80 of EF2 (Figure 313B). Significantly, this tighter interdomain arrangement returns back to the original
looser status when Phe489 is mutated back to Ile489 in the course of a simulation (Figure
3-14). Because EF-hands and C2 domains have been shown to be important for
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enzymatic activity of PLCZ1 and its nuclear translocation (88), this unique interdomain
interaction supports the observed deleterious effect of the mutation.

3.2.7 PAWP does not rescue PLCZ1 mutation.
The PAWP protein encoded by WBP2NL has been proposed to participate in oocyte
activation and we therefore examined it for possible mutations. Analysis of exome data
from P1 and P2 failed to find any deleterious variant in WBP2NL. It is however well
known that exome sequencing only covers 80-90% of all targeted sequences. WBP2NL
coverage was thus verified and we observed that for both patients all exons and exon
borders had a minimal coverage of 40X; therefore unambiguously confirming the
absence of deleterious variants in WBP2NL in the patients (Figure 3-15). Consistent with
these results, we confirmed by Western blotting normal expression of PAWP (Figure 316A) from sperm extracts of patients and a fertile control prepared from the same number
of sperm (Figure 3-16B). We also examined PAWP localization by IF and in agreement
with previous reports, PAWP reactivity appeared as a compact band around the
equatorial/post-acrosomal area in the sperm of a control fertile human (Figure 3-16B1)
and in the sperm of both patients (Figure 3-16B2). These results show that PAWP is
unable to support activation of human oocytes when PLCZ1 is absent and/or nonfunctional. To extend these results to mice, we examined the expression of PAWP in the
sperm of Dpy19l2 KO males whose sperm are globozoospermic, do not contain Plcz1,
and where ICSI of these sperm fails to induce oocyte activation (183, 184). We show that
PAWP expression is normal in these sperm (Figure 3-17), showing that even though
PAWP is present in the injected globozoospermic mouse sperm, it is unable to rescue
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oocyte activation. Altogether, these experiments demonstrate that PAWP is not able by
itself to initiate oocyte activation in humans or mice.

3.3 Discussion

In this study we first investigated the underlying functional defects of sperm from three
patients that either had low or failed fertilization after ICSI during cycles performed in
calendar years 2010 and 2012 despite having normal SA parameters. None of the patients
conceived during this period. We found these sperm largely failed to initiate robust
[Ca2+]i oscillations, although two of these three patients had ~10% of sperm capable of
initiating moderate [Ca2+]i responses in mouse eggs. The expression levels of PLCZ1
were severely reduced in all patients and, more importantly, in the few sperm that
expressed PLCZ1 the distribution and/or intensity were affected. Our results suggest that
abnormal PLCZ1 expression is likely to underlie most cases of ICSI failure, even when
SA parameters are grossly normal.

3.3.1 ICSI Failure and sperm morphology
ICSI is a highly successful technique that overcomes the most severe cases of male
infertility. Nevertheless, low fertilization or fertilization failures after ICSI occur in ~4%
of ICSI cases (148, 179), and the great majority of those cases show a consistent
phenotype; namely, absence of egg activation (185). In addition, research has shown that
ICSI failure is observed in a disproportionate number of patients with globozoospermia
(148, 186). While the precise molecular defect(s) that underlie these patients’ infertility
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remains to be resolved; these sperm tend to have defects in the organization of the sperm
head, including the perinuclear theca and the equatorial regions (187), which are the sites
where purportedly PLCZ1 is located (98, 188). We first reported that globozoospermic
sperm from patients that failed ICSI showed reduced or absent expression of PLCZ1 (98).
A recent study has extended the association of globozoospermia and infertility to the
mouse in the form of the loss or point mutations in the DPY19L2 gene, which encodes for
an inner nuclear membrane protein. The lack of normal DPY19L2 expression has been
associated with disruption of the sperm perinuclear area, globozoospermia and
subsequent infertility (189, 190). Thus, it appears that abnormal sperm head organization,
especially in the perinuclear theca and equatorial regions, which may affect the anchoring
and/or the stability of PLCZ1, is associated with inability of the sperm to initiate [Ca2+]i
responses and egg activation. Interestingly, the OAT patient, who was used as a negative
control in this study, fell in this category.
ICSI failure has also been reported to occur in a few patients with apparent normal
gross sperm morphology (99, 148). In one case, after careful analysis of the PLCZ1 gene
sequence, point mutations that undermined the activity of the enzyme were found in the
catalytic region of PLCZ1, providing a molecular explanation for the lack of egg
activation and infertility observed in the patient (6, 99). We found three patients that
despite displaying normal gross sperm morphology and SA parameters failed or had low
fertilization after ICSI. The sperm of these patients displayed greatly reduced PLCZ1
expression, which might underlie the failure to initiate [Ca2+]i responses regardless of
whether or not point mutations were present in PLCZ1; nevertheless, we cannot exclude
the possibility that mutations in the enzyme of those patients could further compromise
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the function of the enzyme. Also, because we did not carry out EM studies, we cannot
exclude the possibility of abnormal perinuclear theca organization in these sperm
contributing to the abnormal expression and/or distribution of PLCZ1 in those patients. A
recent study from another group also found reduced expression of PLCZ1 in patients that
failed ICSI, although they also found variable expression levels in control, fertile patients
(6). Quantification of PLCZ1 expression in that study was performed by
immunofluorescence; whereas in our previous (98) and current study quantification was
performed by immunoblotting, and the differences in methodology may account for the
large variation observed in that study (6). Further, it is worth pointing out that in the
aforementioned study the level of PLCZ1 expression was low in all infertile patients and
the variability of PLCZ1 expression among failed ICSI patients was also lower than
among fertile patients (6). Therefore, in the presence of failed fertilization after ICSI, low
PLCZ1 levels remain highly predictive of repeated fertilization failure. Collectively, our
results suggest that regardless of sperm morphology, patients that repeatedly fail ICSI or
have low fertilization rates, especially those where acceptable numbers of eggs are
retrieved, are likely to exhibit defects on the ability to induce [Ca2+]i oscillations
associated with defects in PLCZ1 expression and/or function.

3.3.2 [Ca2+]i responses, PLCZ1 expression and low ICSI success
In a previous study we found that sperm from patients with repeated ICSI failure when
injected into mouse oocytes were mostly unable to initiate [Ca2+]i oscillations; in all cases,
this was associated with reduced expression of PLCZ1 (98). In that study, the sperm of
the patients examined displayed severe globozoospermia or obvious morphology defects
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that, as we reported then and was later confirmed by other studies, correlate with the loss
of PLCZ1 (98, 99). In the present study, we focused on patients that despite showing
grossly normal sperm morphology and SA parameters were unable to fertilize ICSI.
Whether or not these types of ICSI failure are also associated with reduced ability to
induce [Ca2+]i responses and defective PLCZ1 expression has not been closely
investigated. We found that ~20% of these sperm were capable of initiating robust [Ca2+]i
responses and another 20% had the capacity to initiate moderate to low [Ca2+]i responses;
while 30 to 50% of the sperm were unable to initiate [Ca2+]i responses. None of the sperm
of the single patient in the study with abnormal morphology were able to initiate robust
responses, although ~60% of the sperm induced moderate to low responses. Collectively,
this data fits nicely with western blots results showing that the levels of PLCZ1
expression in these patients were ~40 to 80% lower than those of control sperm. It is
worth noting that [Ca2+]i monitoring was performed in mouse eggs, which are believed to
be more sensitive to IP3 than human eggs, and therefore only those sperm capable of
initiating robust responses in mouse eggs might be capable of initiating moderate [Ca2+]i
responses in human eggs, which might explain that fertilization failure observed in these
patients.
Next we addressed the question of whether the low expression of PLCZ1 was uniform
in every sperm or rather was due to a few sperm expressing normal amounts of PLCZ1
and others expressing none. To accomplish this, we examined PLCZ1 expression in
individual sperm using IF. In patients FF1, FF2 and FF3, less than 30% of the sperm
showed reactivity after IF, which was in marked contrast to the nearly 70% of the sperm
that displayed reactivity in the control patient. In the OAT patient with abnormal
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morphology less than 5% of the sperm displayed reactivity. Thus, our results suggest that
patients that have low fertilization after ICSI, not only are the overall expression of
PLCZ1 reduced, but the number of sperm expressing PLCZ1 is also affected. Similar
results have recently been reported in a larger study evaluating PLCZ1 expression in
sperm from control and failed fertilization patients (6). Given that single sperm are
selected and injected during the ICSI procedure, the possibility of identifying and using
those sperm that express PLCZ1 and are capable of initiating [Ca2+]i responses is
intriguing and may increase the chances of successful fertilization. Selection of these
sperm could be aided by approaches such as motile sperm organelle morphology
examination (MSOME) that enables evaluation of nuclear morphology in motile
spermatozoa in real time and under high magnification. The selected sperm could then be
used for intracytoplasmic injection (191, 192). A recent manuscript showed that such a
selection might be associated with higher levels of PLCZ1 expression (181).
In summary, we found that low fertilization and failed fertilization after ICSI can occur
in patients with normal gross sperm morphology and is likely associated with defects in
PLCZ1 expression and/or function. Despite that the proportion of sperm expressing
PLCZ1 being severely reduced in these patients, some sperm retain PLCZ1 expression
and are capable of initiating robust [Ca2+]i responses. These findings have clinical
implications, as selection of the [Ca2+]i oscillation-competent sperm may overcome the
severe fertilization defects observed in patients with repeated low fertilization or failed
ICSI.
Our previous studies did not address the role of PAWP, which has been proposed as an
alternative sperm factor candidate (105, 107). Nevertheless, controversial results have
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been published, as a group other than the group proposing the role of PAWP has failed to
replicate the results (108, 109). Further, it is presently unclear how PAWP can lead to the
production of IP3 and Ca2+ responses. Also we did not examine the genomic status of the
PLCZ1 gene in our patients. Genetic diseases are a unique way to demonstrate the role of
a protein in a disorder, and our understanding of reproduction, including gametogenesis
and fertilization, has benefited from the genetic characterization of several phenotypes of
male and female infertilities (193). In humans, a link between oocyte activation failure
and PLCZ1 was first reported in patients displaying abnormal expression and localization
of PLCZ1 in sperm (98), however, these patients exhibited severe teratozoospermia
genetic defects were not found. The first genetic evidence was provided by Heytens et al.,
who found a heterozygous mutation in the Y catalytic domain of PLCZ1 at position 398,
which caused significant decrease in enzymatic activity (99). It was unclear how this
heterozygous mutation could cause infertility. Subsequently, another heterozygous
mutation was found in the X catalytic domain at position 233, resulting in compound
heterozygosity, which reinforced the link between PLCZ1 and oocyte activation failure
(181). We show the first identified homozygous mutation in PLCZ1 leading to oocyte
activation failure and infertility. Importantly, it is the first whole exomic analysis of a
patient presenting oocyte activation failure, enabling us to identify most, if not all, of the
genetic variants. We identified only four common homozygous variants shared by both
brothers, though three of them were not expected to have deleterious effects, which is in
contrasting to the missense mutation found in PLCZ1. This mutation was not associated
with teratozoospermia and the numbers of normal sperm were well above lower reference
limits (WHO laboratory manual for the examination and processing of human semen-

!

64!

fifth edition). Moreover, the sperm of both brothers showed only slightly reduced DNA
quality, ruling this out as the cause of oocyte activation failure (194, 195). Altogether,
these results indicate that PLCZ1 plays a direct role in mammalian oocyte activation.
Unlike PLCZ1, we show that the PAWP gene was unchanged and the expression and
localization of the protein were normal. There is no evidence that PAWP is defective in
the patients’ sperm. This conclusion was reinforced by results using a mouse model of
globozoospermia, Dpy19l2 KO males, exhibiting normal expression of PAWP, despite
their sperm being unable to induce oocyte activation after ICSI (183, 184). Our results,
thus, do not support the notion that PAWP alone triggers Ca2+ responses and oocyte
activation (107); instead, they confirm the importance of PLCZ1 for this function in
human. Finally, molecular modeling of WT and mutant PLCZ1s offers possible insights
into the atomic-level perturbations caused by the nominally homologous I489F mutation.
Molecular dynamics simulation suggests that the large size of the PHE residue results in
displacements of neighboring side chains around the previously buried (ILE) position,
which is predicted to lead to several short, and even long-range, outcomes. Among these,
the shift by approximately 1.5 Å of the EF2-hand helix 1 toward C2 - driven by novel
hydrophobic and H-bonding interactions, and the opening of an aromatic-rich surface
patch capable of associations with hydrophobic counterparts - is the most direct structural
effects for explaining the functional outcome of the mutation which led to abnormal
distribution of PLCZ1, inability to translocate to the PNs, and reduced enzymatic activity.
By changing the structural properties of the C2 domain, this mutation likely modifies
PLCZ1/lipidic membrane interactions; a hypothesis in accordance with our results
showing that PLCZ1 is not retained in sperm and on the reticulum of GV oocytes. The
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Ile489, and likely its neighbors, are thus crucial for the selectivity of the PLCZ1 C2
domain and may explain a unique property of PLCZ that targets intracellular PIP2
localized in the reticulum; contrary to somatic PLCs that hydrolyze mostly the PIP2
localized in the internal leaflet of the plasma membrane (196).
Our results will provide clarification on the mechanism of infertility in these patients
and these data might provide important insights about factors that regulate the function of
PLCZ1. Future studies should determine how rescue the I489F mutant, we propose the
following double mutants (I489F/Y582F, I489F/Y80F).
A significant portion of these data has already been published in the Journal of
Assisted Reproduction Genetics (2014) (197). The data involving the characterization of
PLCZ1I489P expression and function were submitted to Human Molecular Genetics
(2015).
3.4 Materials and Methods
3.4.1 Patients
Following institutional IRB approval, infertile couples undergoing Assisted
Reproductive Technologies at Baystate Medical Center (Springfield, MA) for ICSI were
consented for PLCZ1 analysis of the husbands’ sperm after one or two failed or low
fertilization ICSI cycles. Clinical information regarding antral follicle count (AFC), day 3
FSH levels and peak Estradiol (E2) levels for the three patients were also obtained and
are presented in Table 1. Patients underwent either a long luteal protocol using the
GnRH-analogue (GnRH-a), leuprolide acetate (LA) (Lupron; TAP Phamaceuticals Inc.,
Chicago, IL) or a microdose stimulation protocol using the same analogue (198, 199).
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In PLCZ mutation studies, sperm were obtained from patient consulting at the fertility
department of Grenoble (France) or Clinique des Jasmins (Tunis, Tunisia), following
approval by the ethical committee and informed consent from the patients. All patients
gave an informed consent for the conservation of the remnant sperm in the Germetheque
biobank and their use in studies on human fertility in accordance with the Helsinki
Declaration on human experimentation. Dpy19l2 KO mice were obtained from the
Mutant Mouse Regional Resource Center (MMRRC), University of California, Davis,
CA.
3.4.2 Semen analysis
Freshly ejaculated semen was collected and analyzed for motility, concentration,
viability, and morphology as previously described by us (98). Morphology was evaluated
according to strict Kruger criteria. Sperm were then washed by centrifugation on a
40%/80% PureCeption Percoll gradient (Sage BioPharma, Bedminster, NJ) and the
recovered pellet was washed three times in PBS, after which sperm were prepared for the
different functional or biochemical assays.

3.4.3 Detection of PLCZ1 immunoblotting
Western blotting was performed as previously published by our laboratory (98).
Patients’ sperm were diluted to appropriate concentrations, 2X sample buffer was added
and the samples were kept at –80°C until use. Thawed samples were boiled for 3 minutes,
mixed well and loaded onto 7.5% SDS-PAGE gels and resolved polypeptides were
transferred onto PVDF membranes (Millipore, Billerica, MA) using a Mini Trans-Blot
Cell (Bio-Rad, Hercules, CA). The membranes were blocked in 6% nonfat dry milk in
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PBS–0.1% Tween and incubated overnight at 4°C with the MI-305 antibody (1:500); this
was followed by 1 hour of incubation with a horseradish peroxidase–labeled secondary
antibody (Bio-Rad). Immunoreactivity was detected using chemiluminescence per
manufacturer’s instructions (PerkinElmer, Waltham, MA) using a Kodak Image Station
440CF. Western blotting procedures were repeated at least 2 times per sample.

3.4.4 [Ca2+]i monitoring
[Ca2+]i monitoring was carried out as described by our laboratory (98). In brief, mouse
eggs were loaded with fura-2-acetoxymethyl ester (Fura 2-AM, Molecular Probes;
Invitrogen) prior to performing the ICSI procedure after which eggs were transferred to a
monitoring dish (Mat- Tek Corp., Ashland, MA) containing microdrops of TL-HEPES
medium under mineral oil. Eggs were monitored simultaneously using a 20X objective
on an inverted microscope (Nikon) outfitted for fluorescence measurements and a
temperature-controlled stage. Excitation wavelengths were alternated between 340 nm
and 380 nm using a filter wheel (Ludl Electronic Products Ltd., Hawthorne, NY) and
fluorescence ratios were taken every 20 seconds. After passing through a 510-nm barrier
filter, the emitted light was collected by a CoolSNAPES digital camera (Roper Scientific,
Tucson, AZ). SimplePCI imaging software was used to run all the hardware and capture
images (Hamamatsu, Sewickley, PA). [Ca2+]i values are reported as the ratio of 340
nm:380 nm fluorescence in the whole egg. [Ca2+]i oscillatory activity of human sperm
was scored as previously reported by our laboratory from 0 to +++ according to the
number of [Ca2+]i rises detected within 1 hr of initiating the monitoring (98).
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3.4.5 Immunofluorescence
Patients’ sperm were fixed in freshly made 3.7% PFA-DPBS and kept at 4°C in DPBS
until use, then the suspension was spotted onto 0.1% poly l-lysine (Sigma-Aldrich, St.
Louis, MO) pre-coated multi-well slides (Thermo Scientific, Waltham, MA). Attached
sperm were permeabilized with 0.1% (v/v) Triton X-100–DPBS (Triton X-100; SigmaAldrich) for 5 min at 4°C. Slides were blocked in DPBS+5% normal goat serum
(GIBCO, Invitrogen) and incubated overnight at 4°C with the same primary anti-PLCZ1
antibody MI-305, (1:30) in 5% normal goat serum (98). Washes were performed with
0.1% (v/v) Tween 20–DPBS followed by 1 hr incubation at room temperature in an
Alexa Fluor 555–labeled secondary goat anti-rabbit antibody (1:200) (Invitrogen).
Samples were counterstained with 5 µg/ml Hoechst 33342 (Sigma-Aldrich) and mounted
using mounting media (Vector Laboratories, Burlingame, CA). Fluorescence images
were captured with a Zeiss Axiovert 200M microscope outfitted with a ×63 oil
immersion objective and a Hamamatsu Orca-AG cooled CCD Camera controlled by
AxioVision software 4.6 (Zeiss, Maple Gove, MN). Figures were assembled in
PowerPoint (Microsoft, Redmond, WA).

3.4.6 Generation of constructs and preparation of cRNA
Human and mouse PLCZ1 constructs were kind gifts from Dr. K. Fukami (Tokyo
University of Pharmacy and Life Science, Japan) and Dr. K. Jones (University of
Southampton, UK), respectively. WT h and mPLCZ1-venus sequences were subcloned
into a pcDNA6/Myc-His B (Invitrogen, Carlsbad, CA) between EcoRI and XbaI
restriction sites. hPLCZ1 Ile489Phe and mPlcz1 Ile527Phe were generated by
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substituting Ile to Phe using the Gibson Assembly Cloning Kit (New England Bio Labs,
Ipswich, MA), as previously reported (200). Before performing in vitro transcription, the
sequences of all constructs and presence of mutation sites were confirmed by DNA
sequencing. pDsRed2-ER was kindly provided by Dr. M Trebak (Pen State Hershey
College of Medicine, Hershey, PA). The ER-targeting sequence of calreticulin, DsRed2
and the KDEL ER retention sequence were ligated to pcDNA6/Myc-His B. Plasmids
were linearized outside of the coding region with PmeI and in vitro transcribed using
mMESSAGE/mMACHINE T7 Kit (Ambion, Austin, TX). Poly-A tail was added to the
mRNAs using a Tailing Kit (Ambion).

3.4.7 Preparation of mouse eggs
MII eggs were obtained from superovulated 6- to 10-week-old B6D2F1 (C57BL/6J ×
DBA/2J) female mice as described by our laboratory (139). Eggs were collected in a
HEPES-buffered Tyrode’s lactate solution (TL-HEPES) supplemented with 5% heattreated FCS (GIBCO; Invitrogen, Carlsbad, CA). Cumulus cells were removed with 0.1%
bovine testes hyaluronidase (Sigma-Aldrich) and eggs incubated in CZB medium at
36.5°C under 5% CO2 until the time of injection. All animal studies were approved by the
Animal Care and Use Committee.

3.4.8 ICSI of mouse eggs
MII eggs were injected with patient sperm as described by Kimura and Yanagimachi
(201) and (202) using a piezo micropipette-driven unit (PiezoDrill; Burleigh Instruments
Inc., Rochester, NY). Spare sperm from patients as well as routine sperm analysis
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samples were washed with microinjection buffer (MIB) and frozen at –80°C until
injection, which was performed within a week of collection. Prior to ICSI, human sperm
were thawed and mixed 1:1 with MIB containing 12% PVP. ICSI was performed in
HEPES-buffered CZB medium supplemented with 0.1% polyvinyl alcohol (MW = 30–80
kDa).

3.4.9 Exome Sequencing and bioinformatics analysis
Genomic DNA was isolated from saliva using Oragen DNA extraction kit
(DNAgenotech®, Ottawa, Canada). Coding regions and intron/exon boundaries using the
Agilent SureSelect were enriched using the “all Exon V5 kit“ (Agilent Technologies,
Wokingham, UK). DNA sequencing was undertaken at the Genoscope, Evry, France, on
the HiSeq 2000 from Illumina®. Sequence reads were aligned to the reference genome
(hg19) using MAGIC software. Duplicate reads and reads that mapped to multiple
locations in the exome were excluded from further analysis. Depth of sequence coverage
was calculated using « in-house » Perl script calculating separately forward and reverse
reads. Reads with sequence coverage under 10 in at least one of forward or reverse reads
were excluded. Single nucleotide variation (SNV) and small insertion/deletion (indels)
were identified and filtered for quality using an « in-house » software tool that allowed
the production of a list of variants present in the studied patients. Candidate variants were
identified using a combination of bioinformatics tools. All were filtered by comparison to
EVS, the 1000 Genomes Project (1KG) and the ExAc consortium, and those with a minor
allele frequency (MAF) greater than 0.05 for EVS and 0.01 for ExAc were excluded. We
also compared these variants to an « inhouse » database of 56 control exomes obtained
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from subjects from the same geographic origin as our two patients (North Africa). All
variants present in homozygous state in this database were excluded. We used Variant
Effect Predictor (VEP) to predict the impact of the selected variants on transcripts. We
only retained the variant impacting splice donor / receptor region or causing frameshift,
inframe insertion / deletion, stop gain, stop loss or missense.

3.4.10 Confocal microscopy of florescent-PLCZ1
Live-cell images of oocytes expressing fluorescently tagged proteins were captured
with a confocal laser-scanning microscope (LSM 510 META, Carl Zeiss) using a 63 X
1.4 numerical aperture oil-immersion objective lens. Images were reconstructed using
LSM software (Carl Zeiss). Eggs were maintained in HCZB medium and those
expressing Venus-hPLCZ1 and DsRed-ER proteins were imaged at the GV stage;
whereas expression of Venus-mPlcz1 and DsRed-ER proteins was imaged in PN stage
zygotes.

3.4.11 Parthenogenetic oocyte activation experiments
Oocytes were activated by injection of cRNA PLCZ1 (0.01 µg/µl, concentration in the
pipette) into the ooplasm. After cRNA microinjection, oocytes were cultured in
KSOM/EAA, supplemented with 5 µg/mL cytochalasin B (CB) to diploidize the
parthenotes. The cRNA PLCZ1 injection volume was 5 to 10 pL, which is approximately
1%–3% of the total egg volume. Pronucleus formation was checked at 6 h after ICSI, and
outcomes were scored up to the blastocyst stage.
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3.4.12 Homology modeling
A homology model for hPLCZ1 was generated with the Prime homology modeling
workflow (version 3.8, Schrödinger, LLC) using the structure of rPLCD1, in complex
with inositol-1,4,5-triphosphate and associated Ca2+ (pdb code: 1DJX) as the template.
Briefly, all sequences (1DJX, rPLCD1, and hPLCZ1) were initially aligned by the
BLAST homology search. First, a contiguous template structure was generated by
replacing the missing 445–486 loop in the rPLCD1 structure with a peptide bond between
the proximal (per 1DJX) G444 and K487 and minimization of the resulting loop using the
OPLS2005 force field within Prime. Next, a similar operation resulted in the exclusion of
the basic loop from the catalytic domain of hPLCZ1 (304–344) by linking residues 303
ad 345 to recreate a contiguous mode. A single-chain, liganded model, comprising the
residues 64–303 and 345– 608, was then built via the energy-based algorithm in Prime to
construct and refine non-identical residues and loops with deletions and insertions.

3.4.13 Molecular dynamics simulations
Both the resulting complex and pre-minimized I489F mutant were subjected to an
unconstrained 1.2-ns, molecular dynamics procedure within Desmond (version 4.0, D. E.
Shaw Research & Schrödinger, LLC). A NPT ensemble was built at 300K and 1 atm with
neutralized (by 10 Cl– ions) system and further Na+/Cl– ions to simulate 150 mM
concentration in an explicit SPC solvent model. The interactions that both I489 and the
corresponding phenylalanine were participating throughout the simulations were
identified using the Simulated Interaction Diagram routine within Desmond. Topological
changes were detected using Simulated Event Analysis program by monitoring the
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CαI76–CαI489 and CαI76–CαF489 distances and root mean square fluctuations (RMSF)
as a function of simulation time. The mutant structure from the final frame was modified
back to contain I489, and a simulation under the identical conditions was conducted to
ascertain the persistence of the mutant’s conformation.
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CHAPTER 4
CONCLUSIONS
The first aim of our studies focused on examining the role of TRPV3 channels in Ca2+
homeostasis in oocytes and eggs. During maturation, TRPV3 is differentially expressed
in oocytes, being only fully active at MII stage. At this stage, specific stimulation of
TRPV3 channels promotes Ca2+ influx sufficient to induce egg activation. Subsequently,
we used TrpV3 overexpression, DsRNA, and inhibitors of protein synthesis to modify the
native expression of the channel to learn about its precise timing of expression and
function. We showed that TRPV3 protein is synthesized and translocated to the plasma
membrane during maturation. We also demonstrated that 2-APB promotes Ca2+ influx,
and reversibly targets TRPV3 channels, without blocking the IP3 receptor. Lastly, we
showed that TRPV3 channels functionally interact with the actin cytoskeleton indicating
an actin-based regulation of its expression on the plasma membrane. Together, our results
suggest that TRPV3 is a target of 2-APB in mouse eggs, which can be used to induce
parthenogenesis. The association of endogenous TRPV3 channels with the actin
cytoskeleton is a novel finding, and suggests that the rearrangements of actin that occur
during maturation could regulate both the plasma membrane presence and function of
TRPV3 and other Ca2+ channels involved in oocyte maturation and fertilization. Future
studies should attempt to develop better activators of this channel to be used in
parthenogenesis in mouse and rats. In addition, studies should focus on discovering other
plasma membrane channels in mouse as well as in other mammalian eggs that could
possibly participate in the support of fertilization-initiated oscillations. This knowledge
could then be used to develop activators or inhibitors for these channels that will find
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application in the clinic as methods of parthenogenesis or, conversely, as possible targets
for non-hormonal contraception.
Studies in the second aim focused on the role of PLCZ1 in Ca2+ homeostasis. We
show that the expression level of PLCZ1 in sperm is directly related to the sperm’s ability
to induce [Ca2+]i responses. For example, male partners of failed or low success after
ICSI fertilization showed low expression levels of PLCZ1 or mislocalized PLCZ1 even
tough their semen analysis parameters were normal. Further, in our last study we showed
that PLCZ1 might be the only molecule required for the initiation of oscillations during
fertilization, as the only defect found in two infertile brothers exhibiting normal sperm
morphology but complete fertilization failure after ICSI was a mutation in the coding
sequence of PLCZ1. Using whole exomic sequencing of these brothers found a missense
homozygous mutation in PLCZ1, converting Isoleucine 489 into Phenylalanine
(Ile489Phe); this mutation was not found on a third brother who was fertile. We showed
the mutation was deleterious, leading to absence of the protein in sperm. In addition,
injection of a cRNA into mouse GV and MII oocytes with a point mutation similar to that
found in those patients, showed the protein was mislocalized and produced highly
reduced Ca2+ transients and early embryonic arrest. Altogether these alterations are
consistent with our patients’ sperm inability to induce oocyte activation and initiate
embryo development. Furthermore, it is the first mutation located in the C2 domain of
PLCZ1, a domain involved in targeting proteins to cell membranes, opening the door for
structure function studies to define the conserved amino acids on the β1 strand of the C2
domain that might regulate the selectivity of PLCZ1 for its lipid substrate(s). Finally,
these patients showed normal expression of the PAWP protein, which was suggested to
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also participate in inducing oscillations in mouse eggs. Therefore, our results together
with the findings of a PAWP KO mouse strongly suggest that PAWP is not involved in
initiating Ca2+ responses in mammalian oocytes.
Despite our findings directly demonstrating the involvement of PLCZ1 in oocyte
activation in mammalian, important aspects of its activation and function remain to be
discovered. For example, how is the protein maintained seemingly inactive in sperm until
the time of fertilization? Where is the localization of is substrate in eggs? Lastly, and
more specific to our results, we still do not know why PLCZI489F induces infertility. Is
this due to misfolding of the protein that leads to its degradation? What about the reasons
behind its lower activity and abnormal distribution? Does the mutation change the
affinity of the substrate? Finding answers to some of these questions might provide
important insights into the functioning of PLCZ1, which should contribute to alleviate
human male infertility.
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APPENDIX A
TABLES
TABLE 1
Table 1. Fertilization, pregnancy outcomes, stimulation and sperm parameters in patients
with successful (SF1) and unsuccessful (FF1-3 and OAT) fertilization ICSI
outcomes
Female Parameters

Patients

Age
(years)

Day3
FSH
(IU)

Peak
E2
(pmol/l)

SF1

29

5.3

FF1

39

FF2
FF3
OAT

4

Sperm parameters

AFC
1

Fertilization
2
(#2PN/#OOC )

Pregnanc
y
(Y/N)

Motility
(%)

Concentration
6
(X 10 )

Morphology
(%)

1526

21

10/11

Y

74

45.75

5

8.5

2303

7

0/6;2/8

N

47

23

4.5

36

5.9

2102

19

0/6

N

55

73

5

30

8.7

1167

11

1/5

N

49

41

6

42

6.2

3132

18

1/13

N

17

4.2

2

1

AFC. Antral follicular count.
PN stands for pronuclei. Ooc stands for oocytes.
3
Sperm parameters were evaluated according to WHO standard
4
OAT stands for Oligoasthenoteratozoospermia
2
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TABLE 2
Table 2. ICSI outcomes following stimulation cycles with sperm from patient 1 (P1) and
patient 2 (P2). N (number). P1 and P2 are brothers.
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APPENDIX B
FIGURES
FIGURE 1-1

Figure 1-1. Proposed mechanisms the initiation of oscillations in mammalian eggs.
Temporal course of activation events in mouse eggs with a characteristic [Ca2+]i response
and candidate molecules involved in [Ca2+]i oscillation and Ca2+ homeostasis. Image
(Wakai et al., 2011)
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FIGURE 1-2
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Figure 1-2. Schematic architecture of TRP channels
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FIGURE 1-3

Figure 1-3. Schematic architecture of PLCZ1
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FIGURE 2-1

Figure 2-1. TRPV3 in response to 2-APB during oocyte maturation (A-C) Upper panels:
Germinal vesicle (GV) oocyte, Meiosis I (MI) and Meiosis II (MII) eggs. Scale bar: 50
mm. Middle panel: Whole-cell patch-clamp recording in response to 100 mM 2-APB
(black bar). Lower panel: Changes in [Ca2+]i induced by 200 mM 2-APB (red bars; black
= averaged trace. GV, n=19; MI, n=19; MII, n=16) and ionomycin (green bars) in
nominal Ca2+-free solutions (blue bars). (D) Summary of parameters measured at
different stages of oocyte maturation. Left panel: peak current measured at +80 mV in
response to 100 mM 2- APB (GV, n=4; MI, n=3; MII, n=4). Middle panel: Whole-cell
capacitance measurements (pF) (GV, n=4; MI, n=5; MII, n=10). Right panel: Peak fura-2
ratio, reflecting relative [Ca2+]i. Data are averages ± S.E.M. Scale bar: 50 mm.
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FIGURE 2-2

Figure 2-2. The TRPV3 channel agonist, carvacrol, induces Ca2+ responses and activation
in MII mouse eggs. (A) Changes in [Ca2+]i induced by TRPV3 channels activated by 50
mM carvacrol (violet), 200 mM 2-APB (red), and ionomycin (green) in TrpV3+/- and
TrpV3-/- cells (V3-Het, n=4; V3-KO, n=4). (B) Activation of TrpV3+/-, but not TrpV3-/eggs, by treatment with 50 mM carvacrol (37°C, 10 min). Arrows indicate PN formation
(5 hr, left panel) and cell cleavage (24 hr, left panel). (C) Percentages of PN formation in
WT (TrpV3+/+, CD1 strain), heterozygous (TrpV3+/-) and V3-KO (TrpV3-/-) eggs 5-6 hr
after carvacrol activation. Numbers of eggs undergoing PN formation/total number of
eggs is indicated. (D) Percentage of eggs cleaved after 24 hr exposure to carvacrol.
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Numbers of 2, 3, or 4-cell blastomeres over the total number of eggs is indicated. Data
are averages ± S.E.M.
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FIGURE 2-3

Figure 2-3. Calcium influx through TRPV3 channels does not contribute to early
development in mouse eggs. (A) Oscillations induced by sperm fertilization in
heterozygous (left, TrpV3+/-, green line, n=12/24 have 5-6 oscillations in 60 min) and V3KO (right) eggs (blue line, n=9/18 have 5-6 oscillations in 60 min). (B) In vitro
fertilization (IVF) rates measured by 2-cell formation after 24 hr of fertilization showed
no difference between V3- Het and V3-KO eggs (71 ± 12 for V3-Het vs. 80 ± 4 for V3KO eggs, p > 0.05). Numbers of 2-cell blastomeres/total number of eggs is indicated.
Data are averages ± S.E.M. (C) [Ca2+]i responses were induced by injection of 0.01
mg/ml mPLCz cRNA (similar responses were obtained by 0.05 mg/ml mPLCz cRNA
injection). [Ca2+]i oscillations (37°C) in a control egg (TrpV3+/-, left panel, n=8) and KO
egg (TrpV3-/-, right panel, n=3). 200 mM 2-APB (red bar) was applied at the end of the
experiment.
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FIGURE 2-4
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Figure 2-4. TRPV3 channels mediate Sr2+ influx and subsequent egg activation. (A)
Results of whole-cell patch-clamp recording (37°C) of MII eggs from heterozygous
(TrpV3+/-, green symbols, n=4) and TrpV3-KO (TrpV3-/-, blue symbols, n=4) mice.
Current-voltage (I-V) relation in 10 mM SrCl2. Inset: Averaged current at -80 mV. (B)
Oscillations induced by Sr2+ in a TrpV3+/- egg (green line, n=6), but not in a TrpV3-KO
egg (blue line, n=8). (C) Sr2+ induces cleavage in V3-Het (left) but not in V3-KO (right)
eggs. (D) Percentage of cleaved eggs after 24 hr of 10 mM Sr2+ treatment. Numbers of 2,
3, or 4-cell blastomeres/total number of eggs is indicated. Data are averages ± S.E.M.
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FIGURE 2-5

Figure 2-5. 2-APB increases [Ca2+]i in mouse eggs by promoting Ca2+ influx. Changes in
[Ca2+]i were induced by repeated application of 200 µM 2-APB in Ca2+-containing media
(left panel) or in Ca2+ free-media (right panel). Note that in Ca2+ free-media application
of 2-APB failed to induce [Ca2+]i changes. Re-addition of Ca2+ caused a delayed increase
in [Ca2+]i (right panel).
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FIGURE 2-6

Figure 2-6. Inhibition of protein synthesis decreases response to 2-APB in oocytes. GV
oocytes were matured in-vitro and responses were evaluated at different time points in
the presence/absence of colcemid (COL) and cycloheximide (CHX) plus colcemid
(COL). Oocytes were exposed to 200 µM 2-APB and [Ca2+]i responses generated at each
time compared. Traces from control (non-treated) oocytes are on left panels; oocytes
treated with COL are on the middle panels, and traces for CHX and COL-treated oocytes
are on right panels (CHX+COL, 20 µg/ml and 0.2 µg/ml, respectively). Changes in
[Ca2+]i were measured at 8, 10 and 12 hr of maturation. Numbers of eggs are indicated in
each graph.

!

89!

FIGURE 2-7
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Figure 2-7. 2-APB causes an increase in [Ca2+]i in GV oocytes over-expressing TRPV3
channels, but down-regulation of endogenous TRPV3 reduces response to 2-APB in
mouse eggs. (A) Non-injected GV oocytes failed to show [Ca2+]i responses to 2-APB
treatment (left panel), whereas oocytes injected with TrpV3 mRNA responded with an
increase in [Ca2+]i (right panel). (B-D) Down-regulation of native TRPV3 channels
compromises the response of eggs to 2-APB. B. RT-PCR from GV oocytes showing
TrpV3 mRNA levels in control and ds-injected GV oocytes. Lanes: 1. Negative control
(No RT reaction), 2. Positive control (T cell cDNA high concentration, sizes: 575 bp and
230 bp), 3. Positive control (T cell cDNA low concentration, size: 587 bp), 4. No RT dsVenus control- GVs, 5. Ds-Venus cDNA –GVs (size: 230 bp), 6. No RT dsTrpV3 control,
7. dsTrpV3 –GVs (size: 230 bp). Right Panel: Bar graph showing relative levels of
mTrpV3 normalized to the control mRNA levels of mTrpV3. (D) Changes in [Ca2+]i
induced by exposures to 2-APB, 50 µM (black arrows) in control non-injected eggs (left
panel), and dsTrpV3 RNA injected MII eggs (right panel). (D) Changes in [Ca2+]i
induced by exposures to 2-APB, 50 µM (black arrows) in control non-injected eggs (left
panel), and dsVenus RNA injected MII eggs (right panel).
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FIGURE 2-8

Figure 2-8. Over-expressed RFP-TRPV3 channels localize to the plasma membrane of
mouse oocytes, eggs and zygotes. GV oocytes were injected with mRNA encoding
Rfp-mTrpV3 and incubated for 8 hr to assure protein synthesis prior to being released to
resume maturation. GV oocytes were maintained in IBMX (100 µM) (upper panel) or
matured 12-14 hr in-vitro to the MII stage (middle panel). 10-15% of matured eggs
showed spontaneous PN progression (lower panel). Minor staining was observed in the
cytoplasm, especially after cells had resumed meiosis.
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FIGURE 2-9

Figure 2-9. LatA impairs TRPV3 function in eggs. (A) Changes in [Ca2+]i responses to
200 µM 2-APB were evaluated in control eggs (left panel) and in eggs incubated with
LatA (LatA 5 µM, 30 min; right panel). (B) Quantification of [Ca2+]i responses 5 min
after initiation of response in A. are shown in a bar graph. Note a significant difference
(*, P < 0.05). (C) Changes in oscillations induced by Sr2+ (10 mM SrCl2) were evaluated
in control eggs (left panel, DMSO 0,1%) and in eggs incubated with LatA (LatA 2,5 µM,
right panel; Numbers of eggs are indicated in each graph. DMSO and LatA were added
as indicated by the shaded horizontal bars over the oscillation traces.
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FIGURE 2-10

Figure 2-10. LatA treatment changes the distribution of TRPV3 in oocytes and eggs. The
localization of TRPV3 was analyzed by confocal microscopy in oocytes and eggs
expressing RFP-TRPV3 cultured in absence (Control) or presence of LatA (5 µM). (A-C)
GV oocytes overexpressing TRPV3 ± LatA for3 hr. (A) Control GV oocytes. (B)
Oocytes incubated with LatA. (C) Fluorescence intensity on a line crossing the entire cell
from PM to PM (yellow line, Figure 2-10 A. B., left panel). (D) Ratio of intensity of
fluorescence in cytoplasm vs. PM (*, P < 0.05). Insets show a zoomed area of the PM and
surrounding areas (yellow square). (E-H) MII eggs overexpressing TRPV3 ± 2 hr with
LatA. (E) Control MII eggs. (F) MII eggs treated with LatA. (G) Fluorescence intensity
on a line crossing the entire cell from PM to PM (yellow line, Figure 2-10 E. F., left
panel). H. Ratio of intensity of fluorescence in cytoplasm vs. PM (*, P < 0.05). Insets
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show a zoomed area of the PM and surrounding areas (yellow square). Number of
oocytes/eggs analyzed is indicated inside the bars.
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FIGURE 2-11

Figure 2-11. The function of IP3R1 in mouse eggs is not affected by 2-APB. IP3-induced
Ca2+ release obtained after photolysis of cIP3 by a ﬂash of UV light. Changes in [Ca2+]i
induced by UV-flashes of increasing duration, which are indicated in the graphs, in
control mouse eggs (upper panel) and oocytes and eggs pre-treated with 50 µM 2-APB
(arrow; lower panel). Numbers of eggs evaluated are indicated in each graph.
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FIGURE 3-1

Figure 3-1. DIC and DNA staining images of sperm from successful, SF1, and
unsuccessful, FF1-3 and OAT, fertilization ICSI cases. DIC images, top panels, and same
samples stained with Hoechst to assess nuclear DNA, lower panels, of sperm from FF1-3
and OAT patients, which failed ICSI, and from a control, SF1, patient whose sperm
successfully activated eggs during ICSI.
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FIGURE 3-2

Figure 3-2. [Ca2+]i response-inducing ability of sperm from patients with successful
(SF1) and unsuccessful, FF1-3 and OAT, ICSI. (A) Ca2+ oscillations in mouse eggs
injected with sperm of control the control patient SF1, or with sperm from patients that
failed ICSI, FF1, FF2, FF3 and OAT. n, numerator indicates the number of eggs that
displayed the [Ca2+]i profile shown in each panel, whereas the denominator denotes the
total number of eggs tested.
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FIGURE 3-3

Figure 3-3. PLCZ1 expression in sperm of control, SF1, and failed fertilization, FF1-3
and OAT, ICSI patients. (A) Western blot displaying PLCZ1 IB expression in sperm of a
control, SF1, patient and in the sperm of patients that failed ICSI, FF1, FF2, FF3 and
OAT. The MW of human PLCZ1 is ~ 70 kDa and is denoted by an arrowhead on the
right side of the panel. α-tubulin was used as a loading control, and immunoblots against
it show ~equal loading (lower panels) (B) Bar graph displaying the relative intensity of
the PLCZ1 band in the upper panel. Bars with different superscript are significantly
different (P <0.05). Please note that western blots were run on different dates, as samples
became available. The SF1 sample was prepared once and used for all Immunoblots.
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FIGURE 3-4

Figure 3-4. PLCZ1 localization in SF1, FF1, FF2, and FF3. Using, immunofluorescence
(IF), PLCZ1 is shown to adopt the expected equatorial localization, whereas in FF1-FF3
sperm, the intensity of PLCZ1 reactivity is highly decreased or mis-localized, or both.
Images on the left panels are a combination of bright field, DNA staining and
fluorescence; whereas middle panel show IF images, and the right panels show higher
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magnifications of the IF images. In the lower three panels, yellow arrows denote the
abnormal localization and weak presence of PLCZ1.
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FIGURE 3-5!

Figure 3-5. Spermatocytogram of patients exhibiting oocyte activation failure (OAF)
(A) Table showing semen parameters and spermatocytogram of both patients. Sperm
samples were spread over a slide and dried at RT, fixed in Ether/Ethanol 1:1 for HarrisSchorr staining. Sperm were then scored according to WHO’s laboratory manual for
examination and processing of human semen (FIFTH edition). Values are the average of
two separate analyses. (B) Examples of sperm morphology in samples. * Indicates fully
normal spermatozoa.
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FIGURE 3-6

Figure 3-6. Morphology of acrosome stained with anti-acrosin antibody and assessment
of nucleus compaction and DNA breaks of sperm from OAF patients (A) Negative
control experiment with addition of secondary antibody without primary antibody. (B-D)
Acrosin staining (green staining, B2-D2) of sperm from subjects with normal fertility (B)
and from OAF patients (C, D) counterstained with Hoechst (blue, B1-D1) to evidence the
nucleus/acrosome ratio. The third column corresponds to overlay (B3-D3). (E) Histones
content of sperm was assessed using the aniline blue (AB) test. The histogram shows %
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of stained sperm in samples from control (n=5 ± SD) and patients (n=1). (F)
Protamination of sperm was evaluated using the chromomycin A3 test, and results are
displayed in the histogram, which shows % of stained sperm in control (n=5 ± SD) and
patients’ (n=1) samples. (G) Histogram of DNA fragmentation analysis with TUNEL
assay showing level of TUNEL positive sperm in control (n=5 ± SD) and patients’ (n=1)
samples.
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FIGURE 3-7
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Figure 3-7. Novel point mutation in PLCZ1. (A). List of common homozygous variants
present in P1 and P2. Coordinates of all variations are based on the UCSC GRCh37/hg19
assembly. (B) The presence of the identified variation was verified by Sanger sequencing
of PLCZ1 exon 13. Electropherogram of PLCZ1 exon 13 showing the mutated sequence
and sequence obtained from a control individual. The two infertile brothers carried a
homozygous missense mutation (p.Ile489Phe) in PLCZ1 exon 13 whereas the fertile
brother harbors the mutation in a heterozygous state. Primers were as followed:
PLCZ1_14F:
TCAATGTTTGTGGGAGCTGA
and
PLCZ1_14R:
GGACATAATGGAAAACCCTTG. Thirty-five cycles of PCR amplification were
carried out at 60°C. Sequencing reactions were carried out with BigDye Terminator v3.1
(Applied Biosystems) and sequence analysis with ABI 3130XL (Applied Biosystems).

!

106!

FIGURE 3-8

E

Figure 3-8. The Ile489Phe mutation is located in the C2 domain of PLCZ1. (A)
Schematic representation of the exomic structure of human PLCZ1 cDNA sequence and
corresponding functional domains of PLCZ1 (http://www.uniprot.org/uniprot/Q86YW0).
The first coding exon is exon 2 (exon sizes are not to scale). The mutation is located in
exon 13 and changes Isoleucine 489 located in the C2 domain into a Phenylalanine. (B)
The mutation is located in a cluster of 15 highly conserved amino acids. (C, D) PLCZ1
expression is undetectable by IF and WB in sperm of patients exhibiting oocyte
activation failure (OAF) after ICSI. (C1) Overlay of Hoechst staining (blue) and PLCZ1
staining (green) of sperm from a fertile control patient showing strong immunoreactivity
in the post acrosomal area (white arrow heads and inset) and to a lesser extent in the
acrosome. (C2) Representative staining of sperm from patients with OAF showing
absence of PLCZ1 staining in the post acrosomal area and very faint staining over the
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acrosome. (D) WB using protein extracts of sperm from a fertile control (Ctl), or patient
1 (P1) and patient 2 (P2) and an anti-PLCZ1 antibody that fails to detect reactivity in the
patients’ lanes. (E) Protein gel representing loading control for Figure 3-8D showing that
all lanes were similarly loaded. Protein loads were controlled with TGX stain free™
precast gels.

!

108!

FIGURE 3-9
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Figure 3-9. Mislocalization of PLCZ1 following expression in GV and MII oocytes. (A)
Venus tagged human PLCZ1 cRNA (green) was co-injected in mouse GV stage oocytes
with ER-DsRed cRNA as a marker of the endoplasmic reticulum (red). Both PLCZ1 and
ER-DsRed exhibited a widespread punctiform staining throughout the cytoplasm and the
overlay shows mostly overlapping distribution of the signals. (B) Co-injection of
Ile489Phe PLCZ1 and ER-DsRed resulted in different distribution, with most of the
PLCZ1 staining (green) concentrated around the nucleus (GV); whereas ER-DsRed
remained uniformly distributed in the cytoplasm; there was minimal overlap of the
signals at the oocyte periphery. (C) cRNAs encoding for WT mPlcz1 and the equivalent
mutant in mice, Ile527Phe, were injected in MII oocytes and their ability to translocate
into the PN compared. Where WT Plcz1 (left images) concentrated on the PN, Ile527Phe
Plcz1 did not (right images).
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FIGURE 3-10

Figure 3-10. Ile489Phe PLCZ1 induces fewer Ca2+ oscillations compromising embryo
development. (A) Injection of hPLCZ1 cRNA (0.001 µg/µl) in MII mouse oocytes
triggered high frequency Ca2+ oscillations, 6 and 10 rises per hour that end by 120 - 180
min after injection. (B) In contrast, injection of cRNA of Ile489Phe hPLCZ1 (0.001
µg/µl) triggered oscillations that are either delayed and with low frequency (17/31) or
failed to initiate them (14/31). (C) Histogram showing means + SD of the frequency of
Ca2+ rises in function of control or Ile489Phe cRNA PLCZ1 concentrations injected into
oocytes; Asterisks indicate significant differences determined by t-test, p<0.01 (D) Rates
of 2PN, 2-cell embryos and blastocysts obtained after injection of WT or Ile489Phe
cRNA PLCZ1 (0.01 µg/µl) in mouse MII oocytes; n corresponds to the number of
injected oocytes.
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FIGURE 3-11

Figure 3-11. Ca2+ responses induced by Ile527Phe mPlcz1 are altered and lead to
defective embryo development. (A) Profile of Ca2+ responses induced by injection of WT
mPlcz1 cRNA (0.01 µg/µL) into mouse oocytes. (B) Ca2+ profiles recorded after injection
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of Ile527Phe mPlcz1 cRNA (the mouse equivalent of Ile489Phe hPLCZ1), show delayed
and reduced response. (C) 2PN formation rates are reduced and delayed when both 0.01
and 0.05 µg Ile527Phe mPlcz1 cRNA cRNA/µl concentrations are used (D) injections of
Ile527Phe mPlcz1 cRNAs do not support embryo development, as the rate of 2-cell
embryos formation was strongly reduced or abolished; n corresponds to the number of
injected MII oocytes.
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FIGURE 3-12

!
Figure 3-12. (A) The site of the Ile489Phe mutation is located at the interface of C2 and
EF-hand domains of PLCZ1 (red box) (B, C) Enlargement of the red box for WT and
mutant PLCZ1. As suggested by molecule dynamics simulation, the mutation results in a
displacement of the surrounding C2 residues (Y582, F601, Y603, and R487) by the larger
side chain of Phe. This reorganization, in turn, leads to novel contacts between C2 and
EF2 hand via persistent hydrophobic (Phe489–Ile76) and H-bonding (Tyr582–Tyr80)
side chain interactions, which shift the entire EF-hand domain toward C2 by
approximately 1.5 Å by the end of the 1.2- ns simulation.
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FIGURE 3-13

!
Figure 3-13. Prediction of Intra C2 domain effect induced by Ile489Phe mutation
(A) Backbone superimposition of the WT (light blue) and Ile489Phe (rustcoloured)
PLCZ1 regions proximal to the mutagenesis site and optimized by molecular dynamics.
Briefly, the homology models of the WT and mutant PLCZ1 were generated with the
Prime homology modeling workflow (version 3.8, Schrödinger, LLC), using the structure
of rPlcz1 (pdb code: 1DJX) as the template. Upon minimization of the models using
Prime's OPLS2005 force field, the models were further optimized via 1.2-ns molecular
dynamics simulations (NPT ensemble, 300K, 1 atm, SPC solvent model, 150 mM NaCl)
within Desmond (version4.0, D. E. Shaw Research & Schrödinger, LLC). The side chain
of the 489 residues is shown as transparent molecular surfaces of the respective colors. In
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the mutant PLCZ1, adjacent aromatic residues (Y582, F601, Y603) move to
accommodate the larger Phe ring, and R487 no longer can or needs to shield Ile489 from
the solvent due to lower hydrophobicity of the aromatic Phe. Taken together, these
changes are predicted to result in the formation of an aromatic-rich binding sub-site,
capable of associating with lipophilic molecules. (B) The molecular surfaces of WT and
mutant PLCZ1 in the vicinity of the 489 residues, demonstrating the formation of a novel
hydrophobic sub-site at the C2/EF hand junction. The basic, acidic hydrophobic and polar
neutral residues shown in blue, red, green and cyan, respectively.
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FIGURE 3-14

Figure 3-14. Molecular dynamics simulations of the WT and Ile489Phe PLCZ1 detect a
shift of the EF2 hand helix proximal to the mutation site. Topological changes were
detected using Simulated Event Analysis program by monitoring the CαI76–CαI489 and
CαI76–CαF489 distances and root mean square fluctuations (RMSF) as a function of

!

117!

simulation time. The mutant structure from the final frame was modified back to contain
Ile489, and a simulation under the identical conditions was conducted to ascertain the
persistence of the mutant’s conformation. (A) The distance between the Cα-Ile76 and CαIle489 atoms of the WT PLCZ1 model is in the 11.0–13.5 Å range (mean: 12.2 Å). (B)
The distance between the Cα-Ile76 and Cα-Phe489 atoms in the mutant model is reduced
to the 9.5–11.5 Å range in the second half of the simulation (mean: 10.7 Å). (C) Finally, a
WT model, with Ile489 incorporated into the final frame structure of the mutant
simulation; returning back to the 11.0–13.0 Å range (Cα-Ile76–Cα-Ile489) by the second
half of the simulation.
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FIGURE 3-15

Figure 3-15. NGS coverage of WBP2NL exonic sequence for patients 1 and 2. The read
depth for each patient is indicated in ordinate. For each patient, the minimal coverage for
the whole coding sequence is 40X. Note that regions of lesser coverage (beginning of
exon 1 and end of exon 6) are the 5’ and 3’ untranslated regions, respectively.
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FIGURE 3-16

Figure 3-16. Normal expression and localization of PAWP in patients with OAF. (A) WB
using protein extracts from sperm of a fertile control (Ctl), patient 1 (P1) and patient 2
(P2) and an anti-PAWP antibody. Immunoreactivity is observed in the lanes of control
and patients’ sperm extracts. (B1) Sperm from a fertile control were stained with antiPAWP antibody and counterstained with Hoechst. Overlay shows that the antibody stains
strongly the postacrosomal area. (B2) Similar staining of sperm from patients 1 and 2,
show the same reactivity to that of the control fertile sperm. (C) Protein gel representing
loading control for Figure 3-16A showing that all lanes were similarly loaded. Protein
loads were controlled with TGX stain free™ precast gels.
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FIGURE 3-17

Figure 3-17. PAWP is expressed normally in globozoospermic sperm from Dpy19l2 KO
males WB of protein extracts from sperm of WT (lane 1) and Dpy19l2 KO mice (lane 2)
using an anti-PAWP antibody. Immmunoreactivity is observed in the form of a strong
band just above 36 kDa, which is near the 37.4 kDa, the expected MW of mouse PAWP.
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